
No change: table 0 2 H
  First character (Section) is value 0: Medical and Surgical
  Second character (Body System) is value 2: Heart and Great Vessels
  Third character (Operation) is value H: Insertion: Putting in a nonbiological appliance that monitors, assists, performs, or prevents a physiological function but does not physically take the place of a body part

No change: First panel of table 0 2 H
  Fourth character (Body Part) has 4 choices.
    First choice is value 0: Coronary Artery, One Artery
    Second choice is value 1: Coronary Artery, Two Arteries
    Third choice is value 2: Coronary Artery, Three Arteries
    Fourth choice is value 3: Coronary Artery, Four or More Arteries
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) has 2 choices.
    First choice is value D: Intraluminal Device
    Second choice is value Y: Other Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Second panel of table 0 2 H
  Fourth character (Body Part) has 5 choices.
    First choice is value 4: Coronary Vein
    Second choice is value 6: Atrium, Right
    Third choice is value 7: Atrium, Left
    Fourth choice is value K: Ventricle, Right
    Fifth choice is value L: Ventricle, Left
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) has 9 choices.
    First choice is value 0: Monitoring Device, Pressure Sensor
    Second choice is value 2: Monitoring Device
    Third choice is value 3: Infusion Device
    Fourth choice is value D: Intraluminal Device
    Fifth choice is value J: Cardiac Lead, Pacemaker
    Sixth choice is value K: Cardiac Lead, Defibrillator
    Seventh choice is value M: Cardiac Lead
    Eighth choice is value N: Intracardiac Pacemaker
    Ninth choice is value Y: Other Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Third panel of table 0 2 H
  Fourth character (Body Part) is value A: Heart
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) has 2 choices.
    First choice is value Q: Implantable Heart Assist System
    Second choice is value Y: Other Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Fourth panel of table 0 2 H
  Fourth character (Body Part) is value A: Heart
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) is value R: Short-term External Heart Assist System
  Seventh character (Qualifier) has 3 choices.
    First choice is value J: Intraoperative
    Second choice is value S: Biventricular
    Third choice is value Z: No Qualifier

FY2026: Fifth panel of table 0 2 H
  Fourth character (Body Part) is value M: Ventricular Septum
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device) has 5 choices.
    First choice is value J: Cardiac Lead, Pacemaker
    Second choice is value K: Cardiac Lead, Defibrillator
    Third choice is value M: Cardiac Lead
    Fourth choice is value N: Intracardiac Pacemaker
    Fifth choice is value Y: Other Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Sixth panel of table 0 2 H
  Fourth character (Body Part) is value N: Pericardium
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) has 6 choices.
    First choice is value 0: Monitoring Device, Pressure Sensor
    Second choice is value 2: Monitoring Device
    Third choice is value J: Cardiac Lead, Pacemaker
    Fourth choice is value K: Cardiac Lead, Defibrillator
    Fifth choice is value M: Cardiac Lead
    Sixth choice is value Y: Other Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Seventh panel of table 0 2 H
  Fourth character (Body Part) has 6 choices.
    First choice is value P: Pulmonary Trunk
    Second choice is value Q: Pulmonary Artery, Right
    Third choice is value R: Pulmonary Artery, Left
    Fourth choice is value S: Pulmonary Vein, Right
    Fifth choice is value T: Pulmonary Vein, Left
    Sixth choice is value V: Superior Vena Cava
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) has 5 choices.
    First choice is value 0: Monitoring Device, Pressure Sensor
    Second choice is value 2: Monitoring Device
    Third choice is value 3: Infusion Device
    Fourth choice is value D: Intraluminal Device
    Fifth choice is value Y: Other Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Eighth panel of table 0 2 H
  Fourth character (Body Part) is value W: Thoracic Aorta, Descending
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) has 5 choices.
    First choice is value 0: Monitoring Device, Pressure Sensor
    Second choice is value 2: Monitoring Device
    Third choice is value 3: Infusion Device
    Fourth choice is value D: Intraluminal Device
    Fifth choice is value Y: Other Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Ninth panel of table 0 2 H
  Fourth character (Body Part) is value W: Thoracic Aorta, Descending
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device) has 6 choices.
    First choice is value 0: Monitoring Device, Pressure Sensor
    Second choice is value 2: Monitoring Device
    Third choice is value 3: Infusion Device
    Fourth choice is value D: Intraluminal Device
    Fifth choice is value R: Short-term External Heart Assist System
    Sixth choice is value Y: Other Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Tenth panel of table 0 2 H
  Fourth character (Body Part) is value X: Thoracic Aorta, Ascending/Arch
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) has 4 choices.
    First choice is value 0: Monitoring Device, Pressure Sensor
    Second choice is value 2: Monitoring Device
    Third choice is value 3: Infusion Device
    Fourth choice is value D: Intraluminal Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: table 0 D D
  First character (Section) is value 0: Medical and Surgical
  Second character (Body System) is value D: Gastrointestinal System
  Third character (Operation) is value D: Extraction: Pulling or stripping out or off all or a portion of a body part by the use of force

No change: First panel of table 0 D D
  Fourth character (Body Part) has 22 choices.
    First choice is value 1: Esophagus, Upper
    Second choice is value 2: Esophagus, Middle
    Third choice is value 3: Esophagus, Lower
    Fourth choice is value 4: Esophagogastric Junction
    Fifth choice is value 5: Esophagus
    Sixth choice is value 6: Stomach
    Seventh choice is value 7: Stomach, Pylorus
    Eighth choice is value 8: Small Intestine
    Ninth choice is value 9: Duodenum
    Tenth choice is value A: Jejunum
    Eleventh choice is value B: Ileum
    Twelfth choice is value C: Ileocecal Valve
    Thirteenth choice is value E: Large Intestine
    Fourteenth choice is value F: Large Intestine, Right
    Fifteenth choice is value G: Large Intestine, Left
    Sixteenth choice is value H: Cecum
    Seventeenth choice is value J: Appendix
    Eighteenth choice is value K: Ascending Colon
    Nineteenth choice is value L: Transverse Colon
    Twentieth choice is value M: Descending Colon
    Twenty-first choice is value N: Sigmoid Colon
    Twenty-second choice is value P: Rectum
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 4: Percutaneous Endoscopic
    Third choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Device) is value Z: No Device
  Seventh character (Qualifier) is value X: Diagnostic

No change: Second panel of table 0 D D
  Fourth character (Body Part) is value Q: Anus
  Fifth character (Approach) has 4 choices.
    First choice is value 3: Percutaneous
    Second choice is value 4: Percutaneous Endoscopic
    Third choice is value 8: Via Natural or Artificial Opening Endoscopic
    Fourth choice is value X: External
  Sixth character (Device) is value Z: No Device
  Seventh character (Qualifier) is value X: Diagnostic

FY2026: Third panel of table 0 D D
  Fourth character (Body Part) has 2 choices.
    First choice is value U: Omentum
    Second choice is value V: Mesentery
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) is value Z: No Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: table 0 F 9
  First character (Section) is value 0: Medical and Surgical
  Second character (Body System) is value F: Hepatobiliary System and Pancreas
  Third character (Operation) is value 9: Drainage: Taking or letting out fluids and/or gases from a body part

No change: First panel of table 0 F 9
  Fourth character (Body Part) has 3 choices.
    First choice is value 0: Liver
    Second choice is value 1: Liver, Right Lobe
    Third choice is value 2: Liver, Left Lobe
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) is value 0: Drainage Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Second panel of table 0 F 9
  Fourth character (Body Part) has 3 choices.
    First choice is value 0: Liver
    Second choice is value 1: Liver, Right Lobe
    Third choice is value 2: Liver, Left Lobe
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) is value Z: No Device
  Seventh character (Qualifier) has 2 choices.
    First choice is value X: Diagnostic
    Second choice is value Z: No Qualifier

FY2026: Third panel of table 0 F 9
  Fourth character (Body Part) has 2 choices.
    First choice is value 4: Gallbladder
    Second choice is value G: Pancreas
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) is value 0: Drainage Device
  Seventh character (Qualifier) is value Z: No Qualifier

FY2026: Fourth panel of table 0 F 9
  Fourth character (Body Part) has 2 choices.
    First choice is value 4: Gallbladder
    Second choice is value G: Pancreas
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) is value Z: No Device
  Seventh character (Qualifier) has 2 choices.
    First choice is value X: Diagnostic
    Second choice is value Z: No Qualifier

FY2026: Fifth panel of table 0 F 9
  Fourth character (Body Part) has 2 choices.
    First choice is value 4: Gallbladder
    Second choice is value G: Pancreas
  Fifth character (Approach) is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Device) is value 0: Drainage Device
  Seventh character (Qualifier) has 3 choices.
    First choice is value D: Transmural
    Second choice is value E: Transpapillary
    Third choice is value Z: No Qualifier

FY2026: Sixth panel of table 0 F 9
  Fourth character (Body Part) has 2 choices.
    First choice is value 4: Gallbladder
    Second choice is value G: Pancreas
  Fifth character (Approach) is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Device) is value Z: No Device
  Seventh character (Qualifier) has 2 choices.
    First choice is value X: Diagnostic
    Second choice is value Z: No Qualifier

FY2026: Seventh panel of table 0 F 9
  Fourth character (Body Part) has 8 choices.
    First choice is value 5: Hepatic Duct, Right
    Second choice is value 6: Hepatic Duct, Left
    Third choice is value 7: Hepatic Duct, Common
    Fourth choice is value 8: Cystic Duct
    Fifth choice is value 9: Common Bile Duct
    Sixth choice is value C: Ampulla of Vater
    Seventh choice is value D: Pancreatic Duct
    Eighth choice is value F: Pancreatic Duct, Accessory
  Fifth character (Approach) has 4 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
    Fourth choice is value 7: Via Natural or Artificial Opening
  Sixth character (Device) is value 0: Drainage Device
  Seventh character (Qualifier) is value Z: No Qualifier

FY2026: Eighth panel of table 0 F 9
  Fourth character (Body Part) has 8 choices.
    First choice is value 5: Hepatic Duct, Right
    Second choice is value 6: Hepatic Duct, Left
    Third choice is value 7: Hepatic Duct, Common
    Fourth choice is value 8: Cystic Duct
    Fifth choice is value 9: Common Bile Duct
    Sixth choice is value C: Ampulla of Vater
    Seventh choice is value D: Pancreatic Duct
    Eighth choice is value F: Pancreatic Duct, Accessory
  Fifth character (Approach) has 4 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
    Fourth choice is value 7: Via Natural or Artificial Opening
  Sixth character (Device) is value Z: No Device
  Seventh character (Qualifier) has 2 choices.
    First choice is value X: Diagnostic
    Second choice is value Z: No Qualifier

FY2026: Ninth panel of table 0 F 9
  Fourth character (Body Part) has 8 choices.
    First choice is value 5: Hepatic Duct, Right
    Second choice is value 6: Hepatic Duct, Left
    Third choice is value 7: Hepatic Duct, Common
    Fourth choice is value 8: Cystic Duct
    Fifth choice is value 9: Common Bile Duct
    Sixth choice is value C: Ampulla of Vater
    Seventh choice is value D: Pancreatic Duct
    Eighth choice is value F: Pancreatic Duct, Accessory
  Fifth character (Approach) is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Device) is value 0: Drainage Device
  Seventh character (Qualifier) has 3 choices.
    First choice is value D: Transmural
    Second choice is value E: Transpapillary
    Third choice is value Z: No Qualifier

FY2026: Tenth panel of table 0 F 9
  Fourth character (Body Part) has 8 choices.
    First choice is value 5: Hepatic Duct, Right
    Second choice is value 6: Hepatic Duct, Left
    Third choice is value 7: Hepatic Duct, Common
    Fourth choice is value 8: Cystic Duct
    Fifth choice is value 9: Common Bile Duct
    Sixth choice is value C: Ampulla of Vater
    Seventh choice is value D: Pancreatic Duct
    Eighth choice is value F: Pancreatic Duct, Accessory
  Fifth character (Approach) is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Device) is value Z: No Device
  Seventh character (Qualifier) has 2 choices.
    First choice is value X: Diagnostic
    Second choice is value Z: No Qualifier

FY2026: table 0 T X
  First character (Section) is value 0: Medical and Surgical
  Second character (Body System) is value T: Urinary System
  Third character (Operation) is value X: Transfer: Moving, without taking out, all or a portion of a body part to another location to take over the function of all or a portion of a body part

FY2026: First panel of table 0 T X
  Fourth character (Body Part) is value B: Bladder
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) is value Z: No Device
  Seventh character (Qualifier) has 2 choices.
    First choice is value 6: Ureter, Right
    Second choice is value 7: Ureter, Left

No change: table 0 V T
  First character (Section) is value 0: Medical and Surgical
  Second character (Body System) is value V: Male Reproductive System
  Third character (Operation) is value T: Resection: Cutting out or off, without replacement, all of a body part

FY2026: First panel of table 0 V T
  Fourth character (Body Part) is value 0: Prostate
  Fifth character (Approach) has 4 choices.
    First choice is value 0: Open
    Second choice is value 4: Percutaneous Endoscopic
    Third choice is value 7: Via Natural or Artificial Opening
    Fourth choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Device) is value Z: No Device
  Seventh character (Qualifier) has 2 choices.
    First choice is value E: Capsule Intact
    Second choice is value Z: No Qualifier

No change: Second panel of table 0 V T
  Fourth character (Body Part) has 17 choices.
    First choice is value 1: Seminal Vesicle, Right
    Second choice is value 2: Seminal Vesicle, Left
    Third choice is value 3: Seminal Vesicles, Bilateral
    Fourth choice is value 6: Tunica Vaginalis, Right
    Fifth choice is value 7: Tunica Vaginalis, Left
    Sixth choice is value 9: Testis, Right
    Seventh choice is value B: Testis, Left
    Eighth choice is value C: Testes, Bilateral
    Ninth choice is value F: Spermatic Cord, Right
    Tenth choice is value G: Spermatic Cord, Left
    Eleventh choice is value H: Spermatic Cords, Bilateral
    Twelfth choice is value J: Epididymis, Right
    Thirteenth choice is value K: Epididymis, Left
    Fourteenth choice is value L: Epididymis, Bilateral
    Fifteenth choice is value N: Vas Deferens, Right
    Sixteenth choice is value P: Vas Deferens, Left
    Seventeenth choice is value Q: Vas Deferens, Bilateral
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) is value Z: No Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Third panel of table 0 V T
  Fourth character (Body Part) has 3 choices.
    First choice is value 5: Scrotum
    Second choice is value S: Penis
    Third choice is value T: Prepuce
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 4: Percutaneous Endoscopic
    Third choice is value X: External
  Sixth character (Device) is value Z: No Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: table 3 0 2
  First character (Section) is value 3: Administration
  Second character (Body System) is value 0: Circulatory
  Third character (Operation) is value 2: Transfusion: Putting in blood or blood products

No change: First panel of table 3 0 2
  Fourth character (Body System / Region) has 2 choices.
    First choice is value 3: Peripheral Vein
    Second choice is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value C: Hematopoietic Stem/Progenitor Cells, Genetically Modified
  Seventh character (Qualifier) is value 0: Autologous

No change: Second panel of table 3 0 2
  Fourth character (Body System / Region) has 2 choices.
    First choice is value 3: Peripheral Vein
    Second choice is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value D: Pathogen Reduced Cryoprecipitated Fibrinogen Complex
  Seventh character (Qualifier) is value 1: Nonautologous

No change: Third panel of table 3 0 2
  Fourth character (Body System / Region) has 2 choices.
    First choice is value 3: Peripheral Vein
    Second choice is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) has 3 choices.
    First choice is value G: Bone Marrow
    Second choice is value X: Stem Cells, Cord Blood
    Third choice is value Y: Stem Cells, Hematopoietic
  Seventh character (Qualifier) has 4 choices.
    First choice is value 0: Autologous
    Second choice is value 2: Allogeneic, Related
    Third choice is value 3: Allogeneic, Unrelated
    Fourth choice is value 4: Allogeneic, Unspecified

No change: Fourth panel of table 3 0 2
  Fourth character (Body System / Region) has 2 choices.
    First choice is value 3: Peripheral Vein
    Second choice is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) has 13 choices.
    First choice is value H: Whole Blood
    Second choice is value J: Serum Albumin
    Third choice is value K: Frozen Plasma
    Fourth choice is value L: Fresh Plasma
    Fifth choice is value M: Plasma Cryoprecipitate
    Sixth choice is value N: Red Blood Cells
    Seventh choice is value P: Frozen Red Cells
    Eighth choice is value Q: White Cells
    Ninth choice is value R: Platelets
    Tenth choice is value S: Globulin
    Eleventh choice is value T: Fibrinogen
    Twelfth choice is value V: Antihemophilic Factors
    Thirteenth choice is value W: Factor IX
  Seventh character (Qualifier) has 2 choices.
    First choice is value 0: Autologous
    Second choice is value 1: Nonautologous

No change: Fifth panel of table 3 0 2
  Fourth character (Body System / Region) has 2 choices.
    First choice is value 3: Peripheral Vein
    Second choice is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value U: Stem Cells, T-cell Depleted Hematopoietic
  Seventh character (Qualifier) has 3 choices.
    First choice is value 2: Allogeneic, Related
    Second choice is value 3: Allogeneic, Unrelated
    Third choice is value 4: Allogeneic, Unspecified

No change: Sixth panel of table 3 0 2
  Fourth character (Body System / Region) is value 7: Products of Conception, Circulatory
  Fifth character (Approach) has 2 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
  Sixth character (Substance) has 13 choices.
    First choice is value H: Whole Blood
    Second choice is value J: Serum Albumin
    Third choice is value K: Frozen Plasma
    Fourth choice is value L: Fresh Plasma
    Fifth choice is value M: Plasma Cryoprecipitate
    Sixth choice is value N: Red Blood Cells
    Seventh choice is value P: Frozen Red Cells
    Eighth choice is value Q: White Cells
    Ninth choice is value R: Platelets
    Tenth choice is value S: Globulin
    Eleventh choice is value T: Fibrinogen
    Twelfth choice is value V: Antihemophilic Factors
    Thirteenth choice is value W: Factor IX
  Seventh character (Qualifier) is value 1: Nonautologous

No change: Seventh panel of table 3 0 2
  Fourth character (Body System / Region) is value 8: Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value B: 4-Factor Prothrombin Complex Concentrate
  Seventh character (Qualifier) is value 1: Nonautologous

No change: Eighth panel of table 3 0 2
  Fourth character (Body System / Region) is value A: Bone Marrow
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) has 7 choices.
    First choice is value H: Whole Blood
    Second choice is value J: Serum Albumin
    Third choice is value K: Frozen Plasma
    Fourth choice is value L: Fresh Plasma
    Fifth choice is value N: Red Blood Cells
    Sixth choice is value P: Frozen Red Cells
    Seventh choice is value R: Platelets
  Seventh character (Qualifier) has 2 choices.
    First choice is value 0: Autologous
    Second choice is value 1: Nonautologous

No change: table 3 E 0
  First character (Section) is value 3: Administration
  Second character (Body System) is value E: Physiological Systems and Anatomical Regions
  Third character (Operation) is value 0: Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

No change: First panel of table 3 E 0
  Fourth character (Body System / Region) is value 0: Skin and Mucous Membranes
  Fifth character (Approach) is value X: External
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 2 choices.
    First choice is value 5: Other Antineoplastic
    Second choice is value M: Monoclonal Antibody

No change: Second panel of table 3 E 0
  Fourth character (Body System / Region) is value 0: Skin and Mucous Membranes
  Fifth character (Approach) is value X: External
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

No change: Third panel of table 3 E 0
  Fourth character (Body System / Region) is value 0: Skin and Mucous Membranes
  Fifth character (Approach) is value X: External
  Sixth character (Substance) has 7 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value 4: Serum, Toxoid and Vaccine
    Third choice is value B: Anesthetic Agent
    Fourth choice is value K: Other Diagnostic Substance
    Fifth choice is value M: Pigment
    Sixth choice is value N: Analgesics, Hypnotics, Sedatives
    Seventh choice is value T: Destructive Agent
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Fourth panel of table 3 E 0
  Fourth character (Body System / Region) is value 0: Skin and Mucous Membranes
  Fifth character (Approach) is value X: External
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: Fifth panel of table 3 E 0
  Fourth character (Body System / Region) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 0: Open
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) is value A: Anti-Infective Envelope

No change: Sixth panel of table 3 E 0
  Fourth character (Body System / Region) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 2 choices.
    First choice is value 5: Other Antineoplastic
    Second choice is value M: Monoclonal Antibody

No change: Seventh panel of table 3 E 0
  Fourth character (Body System / Region) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 3 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective
    Third choice is value A: Anti-Infective Envelope

No change: Eighth panel of table 3 E 0
  Fourth character (Body System / Region) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) has 8 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value 6: Nutritional Substance
    Third choice is value 7: Electrolytic and Water Balance Substance
    Fourth choice is value B: Anesthetic Agent
    Fifth choice is value H: Radioactive Substance
    Sixth choice is value K: Other Diagnostic Substance
    Seventh choice is value N: Analgesics, Hypnotics, Sedatives
    Eighth choice is value T: Destructive Agent
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Ninth panel of table 3 E 0
  Fourth character (Body System / Region) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 4: Serum, Toxoid and Vaccine
  Seventh character (Qualifier) has 2 choices.
    First choice is value 0: Influenza Vaccine
    Second choice is value Z: No Qualifier

No change: Tenth panel of table 3 E 0
  Fourth character (Body System / Region) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: Eleventh panel of table 3 E 0
  Fourth character (Body System / Region) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value V: Hormone
  Seventh character (Qualifier) has 2 choices.
    First choice is value G: Insulin
    Second choice is value J: Other Hormone

No change: Twelfth panel of table 3 E 0
  Fourth character (Body System / Region) is value 2: Muscle
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 2 choices.
    First choice is value 5: Other Antineoplastic
    Second choice is value M: Monoclonal Antibody

No change: Thirteenth panel of table 3 E 0
  Fourth character (Body System / Region) is value 2: Muscle
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

No change: Fourteenth panel of table 3 E 0
  Fourth character (Body System / Region) is value 2: Muscle
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) has 8 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value 6: Nutritional Substance
    Third choice is value 7: Electrolytic and Water Balance Substance
    Fourth choice is value B: Anesthetic Agent
    Fifth choice is value H: Radioactive Substance
    Sixth choice is value K: Other Diagnostic Substance
    Seventh choice is value N: Analgesics, Hypnotics, Sedatives
    Eighth choice is value T: Destructive Agent
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Fifteenth panel of table 3 E 0
  Fourth character (Body System / Region) is value 2: Muscle
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 4: Serum, Toxoid and Vaccine
  Seventh character (Qualifier) has 2 choices.
    First choice is value 0: Influenza Vaccine
    Second choice is value Z: No Qualifier

No change: Sixteenth panel of table 3 E 0
  Fourth character (Body System / Region) is value 2: Muscle
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: Seventeenth panel of table 3 E 0
  Fourth character (Body System / Region) is value 3: Peripheral Vein
  Fifth character (Approach) is value 0: Open
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 5 choices.
    First choice is value 2: High-dose Interleukin-2
    Second choice is value 3: Low-dose Interleukin-2
    Third choice is value 5: Other Antineoplastic
    Fourth choice is value M: Monoclonal Antibody
    Fifth choice is value P: Clofarabine

No change: Eighteenth panel of table 3 E 0
  Fourth character (Body System / Region) is value 3: Peripheral Vein
  Fifth character (Approach) is value 0: Open
  Sixth character (Substance) is value 1: Thrombolytic
  Seventh character (Qualifier) has 2 choices.
    First choice is value 6: Recombinant Human-activated Protein C
    Second choice is value 7: Other Thrombolytic

No change: Nineteenth panel of table 3 E 0
  Fourth character (Body System / Region) is value 3: Peripheral Vein
  Fifth character (Approach) is value 0: Open
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

No change: Twentieth panel of table 3 E 0
  Fourth character (Body System / Region) is value 3: Peripheral Vein
  Fifth character (Approach) is value 0: Open
  Sixth character (Substance) has 12 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value 4: Serum, Toxoid and Vaccine
    Third choice is value 6: Nutritional Substance
    Fourth choice is value 7: Electrolytic and Water Balance Substance
    Fifth choice is value F: Intracirculatory Anesthetic
    Sixth choice is value H: Radioactive Substance
    Seventh choice is value K: Other Diagnostic Substance
    Eighth choice is value N: Analgesics, Hypnotics, Sedatives
    Ninth choice is value P: Platelet Inhibitor
    Tenth choice is value R: Antiarrhythmic
    Eleventh choice is value T: Destructive Agent
    Twelfth choice is value X: Vasopressor
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Twenty-first panel of table 3 E 0
  Fourth character (Body System / Region) is value 3: Peripheral Vein
  Fifth character (Approach) is value 0: Open
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) has 2 choices.
    First choice is value C: Other Substance
    Second choice is value N: Blood Brain Barrier Disruption

No change: Twenty-second panel of table 3 E 0
  Fourth character (Body System / Region) is value 3: Peripheral Vein
  Fifth character (Approach) is value 0: Open
  Sixth character (Substance) is value U: Pancreatic Islet Cells
  Seventh character (Qualifier) has 2 choices.
    First choice is value 0: Autologous
    Second choice is value 1: Nonautologous

No change: Twenty-third panel of table 3 E 0
  Fourth character (Body System / Region) is value 3: Peripheral Vein
  Fifth character (Approach) is value 0: Open
  Sixth character (Substance) is value V: Hormone
  Seventh character (Qualifier) has 3 choices.
    First choice is value G: Insulin
    Second choice is value H: Human B-type Natriuretic Peptide
    Third choice is value J: Other Hormone

No change: Twenty-fourth panel of table 3 E 0
  Fourth character (Body System / Region) is value 3: Peripheral Vein
  Fifth character (Approach) is value 0: Open
  Sixth character (Substance) is value W: Immunotherapeutic
  Seventh character (Qualifier) has 2 choices.
    First choice is value K: Immunostimulator
    Second choice is value L: Immunosuppressive

No change: Twenty-fifth panel of table 3 E 0
  Fourth character (Body System / Region) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 5 choices.
    First choice is value 2: High-dose Interleukin-2
    Second choice is value 3: Low-dose Interleukin-2
    Third choice is value 5: Other Antineoplastic
    Fourth choice is value M: Monoclonal Antibody
    Fifth choice is value P: Clofarabine

No change: Twenty-sixth panel of table 3 E 0
  Fourth character (Body System / Region) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 1: Thrombolytic
  Seventh character (Qualifier) has 2 choices.
    First choice is value 6: Recombinant Human-activated Protein C
    Second choice is value 7: Other Thrombolytic

No change: Twenty-seventh panel of table 3 E 0
  Fourth character (Body System / Region) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

FY2026: Twenty-eighth panel of table 3 E 0
  Fourth character (Body System / Region) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) has 13 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value 4: Serum, Toxoid and Vaccine
    Third choice is value 6: Nutritional Substance
    Fourth choice is value 7: Electrolytic and Water Balance Substance
    Fifth choice is value A: Stem Cells, Embryonic
    Sixth choice is value F: Intracirculatory Anesthetic
    Seventh choice is value H: Radioactive Substance
    Eighth choice is value K: Other Diagnostic Substance
    Ninth choice is value N: Analgesics, Hypnotics, Sedatives
    Tenth choice is value P: Platelet Inhibitor
    Eleventh choice is value R: Antiarrhythmic
    Twelfth choice is value T: Destructive Agent
    Thirteenth choice is value X: Vasopressor
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Twenty-ninth panel of table 3 E 0
  Fourth character (Body System / Region) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) has 4 choices.
    First choice is value C: Other Substance
    Second choice is value N: Blood Brain Barrier Disruption
    Third choice is value Q: Glucarpidase
    Fourth choice is value R: Other Therapeutic Monoclonal Antibody

No change: Thirtieth panel of table 3 E 0
  Fourth character (Body System / Region) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value U: Pancreatic Islet Cells
  Seventh character (Qualifier) has 2 choices.
    First choice is value 0: Autologous
    Second choice is value 1: Nonautologous

No change: Thirty-first panel of table 3 E 0
  Fourth character (Body System / Region) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value V: Hormone
  Seventh character (Qualifier) has 3 choices.
    First choice is value G: Insulin
    Second choice is value H: Human B-type Natriuretic Peptide
    Third choice is value J: Other Hormone

No change: Thirty-second panel of table 3 E 0
  Fourth character (Body System / Region) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value W: Immunotherapeutic
  Seventh character (Qualifier) has 2 choices.
    First choice is value K: Immunostimulator
    Second choice is value L: Immunosuppressive

No change: Thirty-third panel of table 3 E 0
  Fourth character (Body System / Region) is value 4: Central Vein
  Fifth character (Approach) is value 0: Open
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 5 choices.
    First choice is value 2: High-dose Interleukin-2
    Second choice is value 3: Low-dose Interleukin-2
    Third choice is value 5: Other Antineoplastic
    Fourth choice is value M: Monoclonal Antibody
    Fifth choice is value P: Clofarabine

No change: Thirty-fourth panel of table 3 E 0
  Fourth character (Body System / Region) is value 4: Central Vein
  Fifth character (Approach) is value 0: Open
  Sixth character (Substance) is value 1: Thrombolytic
  Seventh character (Qualifier) has 2 choices.
    First choice is value 6: Recombinant Human-activated Protein C
    Second choice is value 7: Other Thrombolytic

No change: Thirty-fifth panel of table 3 E 0
  Fourth character (Body System / Region) is value 4: Central Vein
  Fifth character (Approach) is value 0: Open
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

No change: Thirty-sixth panel of table 3 E 0
  Fourth character (Body System / Region) is value 4: Central Vein
  Fifth character (Approach) is value 0: Open
  Sixth character (Substance) has 12 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value 4: Serum, Toxoid and Vaccine
    Third choice is value 6: Nutritional Substance
    Fourth choice is value 7: Electrolytic and Water Balance Substance
    Fifth choice is value F: Intracirculatory Anesthetic
    Sixth choice is value H: Radioactive Substance
    Seventh choice is value K: Other Diagnostic Substance
    Eighth choice is value N: Analgesics, Hypnotics, Sedatives
    Ninth choice is value P: Platelet Inhibitor
    Tenth choice is value R: Antiarrhythmic
    Eleventh choice is value T: Destructive Agent
    Twelfth choice is value X: Vasopressor
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Thirty-seventh panel of table 3 E 0
  Fourth character (Body System / Region) is value 4: Central Vein
  Fifth character (Approach) is value 0: Open
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) has 2 choices.
    First choice is value C: Other Substance
    Second choice is value N: Blood Brain Barrier Disruption

No change: Thirty-eighth panel of table 3 E 0
  Fourth character (Body System / Region) is value 4: Central Vein
  Fifth character (Approach) is value 0: Open
  Sixth character (Substance) is value V: Hormone
  Seventh character (Qualifier) has 3 choices.
    First choice is value G: Insulin
    Second choice is value H: Human B-type Natriuretic Peptide
    Third choice is value J: Other Hormone

No change: Thirty-ninth panel of table 3 E 0
  Fourth character (Body System / Region) is value 4: Central Vein
  Fifth character (Approach) is value 0: Open
  Sixth character (Substance) is value W: Immunotherapeutic
  Seventh character (Qualifier) has 2 choices.
    First choice is value K: Immunostimulator
    Second choice is value L: Immunosuppressive

No change: Fortieth panel of table 3 E 0
  Fourth character (Body System / Region) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 5 choices.
    First choice is value 2: High-dose Interleukin-2
    Second choice is value 3: Low-dose Interleukin-2
    Third choice is value 5: Other Antineoplastic
    Fourth choice is value M: Monoclonal Antibody
    Fifth choice is value P: Clofarabine

No change: Forty-first panel of table 3 E 0
  Fourth character (Body System / Region) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 1: Thrombolytic
  Seventh character (Qualifier) has 2 choices.
    First choice is value 6: Recombinant Human-activated Protein C
    Second choice is value 7: Other Thrombolytic

No change: Forty-second panel of table 3 E 0
  Fourth character (Body System / Region) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

FY2026: Forty-third panel of table 3 E 0
  Fourth character (Body System / Region) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) has 13 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value 4: Serum, Toxoid and Vaccine
    Third choice is value 6: Nutritional Substance
    Fourth choice is value 7: Electrolytic and Water Balance Substance
    Fifth choice is value A: Stem Cells, Embryonic
    Sixth choice is value F: Intracirculatory Anesthetic
    Seventh choice is value H: Radioactive Substance
    Eighth choice is value K: Other Diagnostic Substance
    Ninth choice is value N: Analgesics, Hypnotics, Sedatives
    Tenth choice is value P: Platelet Inhibitor
    Eleventh choice is value R: Antiarrhythmic
    Twelfth choice is value T: Destructive Agent
    Thirteenth choice is value X: Vasopressor
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Forty-fourth panel of table 3 E 0
  Fourth character (Body System / Region) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) has 4 choices.
    First choice is value C: Other Substance
    Second choice is value N: Blood Brain Barrier Disruption
    Third choice is value Q: Glucarpidase
    Fourth choice is value R: Other Therapeutic Monoclonal Antibody

No change: Forty-fifth panel of table 3 E 0
  Fourth character (Body System / Region) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value V: Hormone
  Seventh character (Qualifier) has 3 choices.
    First choice is value G: Insulin
    Second choice is value H: Human B-type Natriuretic Peptide
    Third choice is value J: Other Hormone

No change: Forty-sixth panel of table 3 E 0
  Fourth character (Body System / Region) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value W: Immunotherapeutic
  Seventh character (Qualifier) has 2 choices.
    First choice is value K: Immunostimulator
    Second choice is value L: Immunosuppressive

No change: Forty-seventh panel of table 3 E 0
  Fourth character (Body System / Region) has 2 choices.
    First choice is value 5: Peripheral Artery
    Second choice is value 6: Central Artery
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 5 choices.
    First choice is value 2: High-dose Interleukin-2
    Second choice is value 3: Low-dose Interleukin-2
    Third choice is value 5: Other Antineoplastic
    Fourth choice is value M: Monoclonal Antibody
    Fifth choice is value P: Clofarabine

No change: Forty-eighth panel of table 3 E 0
  Fourth character (Body System / Region) has 2 choices.
    First choice is value 5: Peripheral Artery
    Second choice is value 6: Central Artery
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
  Sixth character (Substance) is value 1: Thrombolytic
  Seventh character (Qualifier) has 2 choices.
    First choice is value 6: Recombinant Human-activated Protein C
    Second choice is value 7: Other Thrombolytic

No change: Forty-ninth panel of table 3 E 0
  Fourth character (Body System / Region) has 2 choices.
    First choice is value 5: Peripheral Artery
    Second choice is value 6: Central Artery
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

No change: Fiftieth panel of table 3 E 0
  Fourth character (Body System / Region) has 2 choices.
    First choice is value 5: Peripheral Artery
    Second choice is value 6: Central Artery
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
  Sixth character (Substance) has 12 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value 4: Serum, Toxoid and Vaccine
    Third choice is value 6: Nutritional Substance
    Fourth choice is value 7: Electrolytic and Water Balance Substance
    Fifth choice is value F: Intracirculatory Anesthetic
    Sixth choice is value H: Radioactive Substance
    Seventh choice is value K: Other Diagnostic Substance
    Eighth choice is value N: Analgesics, Hypnotics, Sedatives
    Ninth choice is value P: Platelet Inhibitor
    Tenth choice is value R: Antiarrhythmic
    Eleventh choice is value T: Destructive Agent
    Twelfth choice is value X: Vasopressor
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Fifty-first panel of table 3 E 0
  Fourth character (Body System / Region) has 2 choices.
    First choice is value 5: Peripheral Artery
    Second choice is value 6: Central Artery
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) has 2 choices.
    First choice is value C: Other Substance
    Second choice is value N: Blood Brain Barrier Disruption

No change: Fifty-second panel of table 3 E 0
  Fourth character (Body System / Region) has 2 choices.
    First choice is value 5: Peripheral Artery
    Second choice is value 6: Central Artery
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
  Sixth character (Substance) is value V: Hormone
  Seventh character (Qualifier) has 3 choices.
    First choice is value G: Insulin
    Second choice is value H: Human B-type Natriuretic Peptide
    Third choice is value J: Other Hormone

No change: Fifty-third panel of table 3 E 0
  Fourth character (Body System / Region) has 2 choices.
    First choice is value 5: Peripheral Artery
    Second choice is value 6: Central Artery
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
  Sixth character (Substance) is value W: Immunotherapeutic
  Seventh character (Qualifier) has 2 choices.
    First choice is value K: Immunostimulator
    Second choice is value L: Immunosuppressive

No change: Fifty-fourth panel of table 3 E 0
  Fourth character (Body System / Region) has 2 choices.
    First choice is value 7: Coronary Artery
    Second choice is value 8: Heart
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
  Sixth character (Substance) is value 1: Thrombolytic
  Seventh character (Qualifier) has 2 choices.
    First choice is value 6: Recombinant Human-activated Protein C
    Second choice is value 7: Other Thrombolytic

No change: Fifty-fifth panel of table 3 E 0
  Fourth character (Body System / Region) has 2 choices.
    First choice is value 7: Coronary Artery
    Second choice is value 8: Heart
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: Fifty-sixth panel of table 3 E 0
  Fourth character (Body System / Region) has 2 choices.
    First choice is value 7: Coronary Artery
    Second choice is value 8: Heart
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
  Sixth character (Substance) has 2 choices.
    First choice is value K: Other Diagnostic Substance
    Second choice is value P: Platelet Inhibitor
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Fifty-seventh panel of table 3 E 0
  Fourth character (Body System / Region) has 2 choices.
    First choice is value 7: Coronary Artery
    Second choice is value 8: Heart
  Fifth character (Approach) is value 4: Percutaneous Endoscopic
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: Fifty-eighth panel of table 3 E 0
  Fourth character (Body System / Region) is value 9: Nose
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value X: External
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 2 choices.
    First choice is value 5: Other Antineoplastic
    Second choice is value M: Monoclonal Antibody

No change: Fifty-ninth panel of table 3 E 0
  Fourth character (Body System / Region) is value 9: Nose
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value X: External
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

No change: Sixtieth panel of table 3 E 0
  Fourth character (Body System / Region) is value 9: Nose
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value X: External
  Sixth character (Substance) has 7 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value 4: Serum, Toxoid and Vaccine
    Third choice is value B: Anesthetic Agent
    Fourth choice is value H: Radioactive Substance
    Fifth choice is value K: Other Diagnostic Substance
    Sixth choice is value N: Analgesics, Hypnotics, Sedatives
    Seventh choice is value T: Destructive Agent
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Sixty-first panel of table 3 E 0
  Fourth character (Body System / Region) is value 9: Nose
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value X: External
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: Sixty-second panel of table 3 E 0
  Fourth character (Body System / Region) is value A: Bone Marrow
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 2 choices.
    First choice is value 5: Other Antineoplastic
    Second choice is value M: Monoclonal Antibody

No change: Sixty-third panel of table 3 E 0
  Fourth character (Body System / Region) is value A: Bone Marrow
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: Sixty-fourth panel of table 3 E 0
  Fourth character (Body System / Region) is value B: Ear
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value X: External
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 3 choices.
    First choice is value 4: Liquid Brachytherapy Radioisotope
    Second choice is value 5: Other Antineoplastic
    Third choice is value M: Monoclonal Antibody

No change: Sixty-fifth panel of table 3 E 0
  Fourth character (Body System / Region) is value B: Ear
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value X: External
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

No change: Sixty-sixth panel of table 3 E 0
  Fourth character (Body System / Region) is value B: Ear
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value X: External
  Sixth character (Substance) has 6 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value B: Anesthetic Agent
    Third choice is value H: Radioactive Substance
    Fourth choice is value K: Other Diagnostic Substance
    Fifth choice is value N: Analgesics, Hypnotics, Sedatives
    Sixth choice is value T: Destructive Agent
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Sixty-seventh panel of table 3 E 0
  Fourth character (Body System / Region) is value B: Ear
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value X: External
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: Sixty-eighth panel of table 3 E 0
  Fourth character (Body System / Region) is value C: Eye
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value X: External
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 3 choices.
    First choice is value 4: Liquid Brachytherapy Radioisotope
    Second choice is value 5: Other Antineoplastic
    Third choice is value M: Monoclonal Antibody

No change: Sixty-ninth panel of table 3 E 0
  Fourth character (Body System / Region) is value C: Eye
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value X: External
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

No change: Seventieth panel of table 3 E 0
  Fourth character (Body System / Region) is value C: Eye
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value X: External
  Sixth character (Substance) has 7 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value B: Anesthetic Agent
    Third choice is value H: Radioactive Substance
    Fourth choice is value K: Other Diagnostic Substance
    Fifth choice is value M: Pigment
    Sixth choice is value N: Analgesics, Hypnotics, Sedatives
    Seventh choice is value T: Destructive Agent
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Seventy-first panel of table 3 E 0
  Fourth character (Body System / Region) is value C: Eye
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value X: External
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: Seventy-second panel of table 3 E 0
  Fourth character (Body System / Region) is value C: Eye
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value X: External
  Sixth character (Substance) is value S: Gas
  Seventh character (Qualifier) is value F: Other Gas

No change: Seventy-third panel of table 3 E 0
  Fourth character (Body System / Region) is value D: Mouth and Pharynx
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value X: External
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 3 choices.
    First choice is value 4: Liquid Brachytherapy Radioisotope
    Second choice is value 5: Other Antineoplastic
    Third choice is value M: Monoclonal Antibody

No change: Seventy-fourth panel of table 3 E 0
  Fourth character (Body System / Region) is value D: Mouth and Pharynx
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value X: External
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

No change: Seventy-fifth panel of table 3 E 0
  Fourth character (Body System / Region) is value D: Mouth and Pharynx
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value X: External
  Sixth character (Substance) has 10 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value 4: Serum, Toxoid and Vaccine
    Third choice is value 6: Nutritional Substance
    Fourth choice is value 7: Electrolytic and Water Balance Substance
    Fifth choice is value B: Anesthetic Agent
    Sixth choice is value H: Radioactive Substance
    Seventh choice is value K: Other Diagnostic Substance
    Eighth choice is value N: Analgesics, Hypnotics, Sedatives
    Ninth choice is value R: Antiarrhythmic
    Tenth choice is value T: Destructive Agent
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Seventy-sixth panel of table 3 E 0
  Fourth character (Body System / Region) is value D: Mouth and Pharynx
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value X: External
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: Seventy-seventh panel of table 3 E 0
  Fourth character (Body System / Region) has 5 choices.
    First choice is value E: Products of Conception
    Second choice is value G: Upper GI
    Third choice is value H: Lower GI
    Fourth choice is value K: Genitourinary Tract
    Fifth choice is value N: Male Reproductive
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 3 choices.
    First choice is value 4: Liquid Brachytherapy Radioisotope
    Second choice is value 5: Other Antineoplastic
    Third choice is value M: Monoclonal Antibody

No change: Seventy-eighth panel of table 3 E 0
  Fourth character (Body System / Region) has 5 choices.
    First choice is value E: Products of Conception
    Second choice is value G: Upper GI
    Third choice is value H: Lower GI
    Fourth choice is value K: Genitourinary Tract
    Fifth choice is value N: Male Reproductive
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

No change: Seventy-ninth panel of table 3 E 0
  Fourth character (Body System / Region) has 5 choices.
    First choice is value E: Products of Conception
    Second choice is value G: Upper GI
    Third choice is value H: Lower GI
    Fourth choice is value K: Genitourinary Tract
    Fifth choice is value N: Male Reproductive
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Substance) has 8 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value 6: Nutritional Substance
    Third choice is value 7: Electrolytic and Water Balance Substance
    Fourth choice is value B: Anesthetic Agent
    Fifth choice is value H: Radioactive Substance
    Sixth choice is value K: Other Diagnostic Substance
    Seventh choice is value N: Analgesics, Hypnotics, Sedatives
    Eighth choice is value T: Destructive Agent
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Eightieth panel of table 3 E 0
  Fourth character (Body System / Region) has 5 choices.
    First choice is value E: Products of Conception
    Second choice is value G: Upper GI
    Third choice is value H: Lower GI
    Fourth choice is value K: Genitourinary Tract
    Fifth choice is value N: Male Reproductive
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: Eighty-first panel of table 3 E 0
  Fourth character (Body System / Region) has 5 choices.
    First choice is value E: Products of Conception
    Second choice is value G: Upper GI
    Third choice is value H: Lower GI
    Fourth choice is value K: Genitourinary Tract
    Fifth choice is value N: Male Reproductive
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Substance) is value S: Gas
  Seventh character (Qualifier) is value F: Other Gas

No change: Eighty-second panel of table 3 E 0
  Fourth character (Body System / Region) has 5 choices.
    First choice is value E: Products of Conception
    Second choice is value G: Upper GI
    Third choice is value H: Lower GI
    Fourth choice is value K: Genitourinary Tract
    Fifth choice is value N: Male Reproductive
  Fifth character (Approach) is value 4: Percutaneous Endoscopic
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: Eighty-third panel of table 3 E 0
  Fourth character (Body System / Region) is value F: Respiratory Tract
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 3 choices.
    First choice is value 4: Liquid Brachytherapy Radioisotope
    Second choice is value 5: Other Antineoplastic
    Third choice is value M: Monoclonal Antibody

No change: Eighty-fourth panel of table 3 E 0
  Fourth character (Body System / Region) is value F: Respiratory Tract
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

No change: Eighty-fifth panel of table 3 E 0
  Fourth character (Body System / Region) is value F: Respiratory Tract
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Substance) has 8 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value 6: Nutritional Substance
    Third choice is value 7: Electrolytic and Water Balance Substance
    Fourth choice is value B: Anesthetic Agent
    Fifth choice is value H: Radioactive Substance
    Sixth choice is value K: Other Diagnostic Substance
    Seventh choice is value N: Analgesics, Hypnotics, Sedatives
    Eighth choice is value T: Destructive Agent
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Eighty-sixth panel of table 3 E 0
  Fourth character (Body System / Region) is value F: Respiratory Tract
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: Eighty-seventh panel of table 3 E 0
  Fourth character (Body System / Region) is value F: Respiratory Tract
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Substance) is value S: Gas
  Seventh character (Qualifier) has 2 choices.
    First choice is value D: Nitric Oxide
    Second choice is value F: Other Gas

No change: Eighty-eighth panel of table 3 E 0
  Fourth character (Body System / Region) is value F: Respiratory Tract
  Fifth character (Approach) is value 4: Percutaneous Endoscopic
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: Eighty-ninth panel of table 3 E 0
  Fourth character (Body System / Region) is value J: Biliary and Pancreatic Tract
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 3 choices.
    First choice is value 4: Liquid Brachytherapy Radioisotope
    Second choice is value 5: Other Antineoplastic
    Third choice is value M: Monoclonal Antibody

No change: Ninetieth panel of table 3 E 0
  Fourth character (Body System / Region) is value J: Biliary and Pancreatic Tract
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

No change: Ninety-first panel of table 3 E 0
  Fourth character (Body System / Region) is value J: Biliary and Pancreatic Tract
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Substance) has 8 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value 6: Nutritional Substance
    Third choice is value 7: Electrolytic and Water Balance Substance
    Fourth choice is value B: Anesthetic Agent
    Fifth choice is value H: Radioactive Substance
    Sixth choice is value K: Other Diagnostic Substance
    Seventh choice is value N: Analgesics, Hypnotics, Sedatives
    Eighth choice is value T: Destructive Agent
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Ninety-second panel of table 3 E 0
  Fourth character (Body System / Region) is value J: Biliary and Pancreatic Tract
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: Ninety-third panel of table 3 E 0
  Fourth character (Body System / Region) is value J: Biliary and Pancreatic Tract
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Substance) is value S: Gas
  Seventh character (Qualifier) is value F: Other Gas

No change: Ninety-fourth panel of table 3 E 0
  Fourth character (Body System / Region) is value J: Biliary and Pancreatic Tract
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Substance) is value U: Pancreatic Islet Cells
  Seventh character (Qualifier) has 2 choices.
    First choice is value 0: Autologous
    Second choice is value 1: Nonautologous

No change: Ninety-fifth panel of table 3 E 0
  Fourth character (Body System / Region) is value J: Biliary and Pancreatic Tract
  Fifth character (Approach) is value 4: Percutaneous Endoscopic
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: Ninety-sixth panel of table 3 E 0
  Fourth character (Body System / Region) is value L: Pleural Cavity
  Fifth character (Approach) is value 0: Open
  Sixth character (Substance) is value 5: Adhesion Barrier
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Ninety-seventh panel of table 3 E 0
  Fourth character (Body System / Region) is value L: Pleural Cavity
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 3 choices.
    First choice is value 4: Liquid Brachytherapy Radioisotope
    Second choice is value 5: Other Antineoplastic
    Third choice is value M: Monoclonal Antibody

No change: Ninety-eighth panel of table 3 E 0
  Fourth character (Body System / Region) is value L: Pleural Cavity
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 1: Thrombolytic
  Seventh character (Qualifier) is value 7: Other Thrombolytic

No change: Ninety-ninth panel of table 3 E 0
  Fourth character (Body System / Region) is value L: Pleural Cavity
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

No change: One hundredth panel of table 3 E 0
  Fourth character (Body System / Region) is value L: Pleural Cavity
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) has 9 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value 5: Adhesion Barrier
    Third choice is value 6: Nutritional Substance
    Fourth choice is value 7: Electrolytic and Water Balance Substance
    Fifth choice is value B: Anesthetic Agent
    Sixth choice is value H: Radioactive Substance
    Seventh choice is value K: Other Diagnostic Substance
    Eighth choice is value N: Analgesics, Hypnotics, Sedatives
    Ninth choice is value T: Destructive Agent
  Seventh character (Qualifier) is value Z: No Qualifier

No change: One hundred First panel of table 3 E 0
  Fourth character (Body System / Region) is value L: Pleural Cavity
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: One hundred Second panel of table 3 E 0
  Fourth character (Body System / Region) is value L: Pleural Cavity
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value S: Gas
  Seventh character (Qualifier) is value F: Other Gas

No change: One hundred Third panel of table 3 E 0
  Fourth character (Body System / Region) is value L: Pleural Cavity
  Fifth character (Approach) is value 4: Percutaneous Endoscopic
  Sixth character (Substance) is value 5: Adhesion Barrier
  Seventh character (Qualifier) is value Z: No Qualifier

No change: One hundred Fourth panel of table 3 E 0
  Fourth character (Body System / Region) is value L: Pleural Cavity
  Fifth character (Approach) is value 4: Percutaneous Endoscopic
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: One hundred Fifth panel of table 3 E 0
  Fourth character (Body System / Region) is value L: Pleural Cavity
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 3 choices.
    First choice is value 4: Liquid Brachytherapy Radioisotope
    Second choice is value 5: Other Antineoplastic
    Third choice is value M: Monoclonal Antibody

No change: One hundred Sixth panel of table 3 E 0
  Fourth character (Body System / Region) is value L: Pleural Cavity
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Substance) is value S: Gas
  Seventh character (Qualifier) is value F: Other Gas

No change: One hundred Seventh panel of table 3 E 0
  Fourth character (Body System / Region) is value M: Peritoneal Cavity
  Fifth character (Approach) is value 0: Open
  Sixth character (Substance) is value 5: Adhesion Barrier
  Seventh character (Qualifier) is value Z: No Qualifier

No change: One hundred Eighth panel of table 3 E 0
  Fourth character (Body System / Region) is value M: Peritoneal Cavity
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 4 choices.
    First choice is value 4: Liquid Brachytherapy Radioisotope
    Second choice is value 5: Other Antineoplastic
    Third choice is value M: Monoclonal Antibody
    Fourth choice is value Y: Hyperthermic

No change: One hundred Ninth panel of table 3 E 0
  Fourth character (Body System / Region) is value M: Peritoneal Cavity
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

No change: One hundred Tenth panel of table 3 E 0
  Fourth character (Body System / Region) is value M: Peritoneal Cavity
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) has 9 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value 5: Adhesion Barrier
    Third choice is value 6: Nutritional Substance
    Fourth choice is value 7: Electrolytic and Water Balance Substance
    Fifth choice is value B: Anesthetic Agent
    Sixth choice is value H: Radioactive Substance
    Seventh choice is value K: Other Diagnostic Substance
    Eighth choice is value N: Analgesics, Hypnotics, Sedatives
    Ninth choice is value T: Destructive Agent
  Seventh character (Qualifier) is value Z: No Qualifier

No change: One hundred Eleventh panel of table 3 E 0
  Fourth character (Body System / Region) is value M: Peritoneal Cavity
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: One hundred Twelfth panel of table 3 E 0
  Fourth character (Body System / Region) is value M: Peritoneal Cavity
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value S: Gas
  Seventh character (Qualifier) is value F: Other Gas

No change: One hundred Thirteenth panel of table 3 E 0
  Fourth character (Body System / Region) is value M: Peritoneal Cavity
  Fifth character (Approach) is value 4: Percutaneous Endoscopic
  Sixth character (Substance) is value 5: Adhesion Barrier
  Seventh character (Qualifier) is value Z: No Qualifier

No change: One hundred Fourteenth panel of table 3 E 0
  Fourth character (Body System / Region) is value M: Peritoneal Cavity
  Fifth character (Approach) is value 4: Percutaneous Endoscopic
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: One hundred Fifteenth panel of table 3 E 0
  Fourth character (Body System / Region) is value M: Peritoneal Cavity
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 3 choices.
    First choice is value 4: Liquid Brachytherapy Radioisotope
    Second choice is value 5: Other Antineoplastic
    Third choice is value M: Monoclonal Antibody

No change: One hundred Sixteenth panel of table 3 E 0
  Fourth character (Body System / Region) is value M: Peritoneal Cavity
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Substance) is value S: Gas
  Seventh character (Qualifier) is value F: Other Gas

No change: One hundred Seventeenth panel of table 3 E 0
  Fourth character (Body System / Region) is value P: Female Reproductive
  Fifth character (Approach) is value 0: Open
  Sixth character (Substance) is value 5: Adhesion Barrier
  Seventh character (Qualifier) is value Z: No Qualifier

No change: One hundred Eighteenth panel of table 3 E 0
  Fourth character (Body System / Region) is value P: Female Reproductive
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 3 choices.
    First choice is value 4: Liquid Brachytherapy Radioisotope
    Second choice is value 5: Other Antineoplastic
    Third choice is value M: Monoclonal Antibody

No change: One hundred Nineteenth panel of table 3 E 0
  Fourth character (Body System / Region) is value P: Female Reproductive
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

No change: One hundred Twentieth panel of table 3 E 0
  Fourth character (Body System / Region) is value P: Female Reproductive
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) has 11 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value 5: Adhesion Barrier
    Third choice is value 6: Nutritional Substance
    Fourth choice is value 7: Electrolytic and Water Balance Substance
    Fifth choice is value B: Anesthetic Agent
    Sixth choice is value H: Radioactive Substance
    Seventh choice is value K: Other Diagnostic Substance
    Eighth choice is value L: Sperm
    Ninth choice is value N: Analgesics, Hypnotics, Sedatives
    Tenth choice is value T: Destructive Agent
    Eleventh choice is value V: Hormone
  Seventh character (Qualifier) is value Z: No Qualifier

No change: One hundred Twenty-first panel of table 3 E 0
  Fourth character (Body System / Region) is value P: Female Reproductive
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: One hundred Twenty-second panel of table 3 E 0
  Fourth character (Body System / Region) is value P: Female Reproductive
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value Q: Fertilized Ovum
  Seventh character (Qualifier) has 2 choices.
    First choice is value 0: Autologous
    Second choice is value 1: Nonautologous

No change: One hundred Twenty-third panel of table 3 E 0
  Fourth character (Body System / Region) is value P: Female Reproductive
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value S: Gas
  Seventh character (Qualifier) is value F: Other Gas

No change: One hundred Twenty-fourth panel of table 3 E 0
  Fourth character (Body System / Region) is value P: Female Reproductive
  Fifth character (Approach) is value 4: Percutaneous Endoscopic
  Sixth character (Substance) is value 5: Adhesion Barrier
  Seventh character (Qualifier) is value Z: No Qualifier

No change: One hundred Twenty-fifth panel of table 3 E 0
  Fourth character (Body System / Region) is value P: Female Reproductive
  Fifth character (Approach) is value 4: Percutaneous Endoscopic
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: One hundred Twenty-sixth panel of table 3 E 0
  Fourth character (Body System / Region) is value P: Female Reproductive
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 3 choices.
    First choice is value 4: Liquid Brachytherapy Radioisotope
    Second choice is value 5: Other Antineoplastic
    Third choice is value M: Monoclonal Antibody

No change: One hundred Twenty-seventh panel of table 3 E 0
  Fourth character (Body System / Region) is value P: Female Reproductive
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

No change: One hundred Twenty-eighth panel of table 3 E 0
  Fourth character (Body System / Region) is value P: Female Reproductive
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Substance) has 10 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value 6: Nutritional Substance
    Third choice is value 7: Electrolytic and Water Balance Substance
    Fourth choice is value B: Anesthetic Agent
    Fifth choice is value H: Radioactive Substance
    Sixth choice is value K: Other Diagnostic Substance
    Seventh choice is value L: Sperm
    Eighth choice is value N: Analgesics, Hypnotics, Sedatives
    Ninth choice is value T: Destructive Agent
    Tenth choice is value V: Hormone
  Seventh character (Qualifier) is value Z: No Qualifier

No change: One hundred Twenty-ninth panel of table 3 E 0
  Fourth character (Body System / Region) is value P: Female Reproductive
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: One hundred Thirtieth panel of table 3 E 0
  Fourth character (Body System / Region) is value P: Female Reproductive
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Substance) is value Q: Fertilized Ovum
  Seventh character (Qualifier) has 2 choices.
    First choice is value 0: Autologous
    Second choice is value 1: Nonautologous

No change: One hundred Thirty-first panel of table 3 E 0
  Fourth character (Body System / Region) is value P: Female Reproductive
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Substance) is value S: Gas
  Seventh character (Qualifier) is value F: Other Gas

No change: One hundred Thirty-second panel of table 3 E 0
  Fourth character (Body System / Region) is value P: Female Reproductive
  Fifth character (Approach) is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 3 choices.
    First choice is value 4: Liquid Brachytherapy Radioisotope
    Second choice is value 5: Other Antineoplastic
    Third choice is value M: Monoclonal Antibody

No change: One hundred Thirty-third panel of table 3 E 0
  Fourth character (Body System / Region) is value P: Female Reproductive
  Fifth character (Approach) is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

No change: One hundred Thirty-fourth panel of table 3 E 0
  Fourth character (Body System / Region) is value P: Female Reproductive
  Fifth character (Approach) is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Substance) has 8 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value 6: Nutritional Substance
    Third choice is value 7: Electrolytic and Water Balance Substance
    Fourth choice is value B: Anesthetic Agent
    Fifth choice is value H: Radioactive Substance
    Sixth choice is value K: Other Diagnostic Substance
    Seventh choice is value N: Analgesics, Hypnotics, Sedatives
    Eighth choice is value T: Destructive Agent
  Seventh character (Qualifier) is value Z: No Qualifier

No change: One hundred Thirty-fifth panel of table 3 E 0
  Fourth character (Body System / Region) is value P: Female Reproductive
  Fifth character (Approach) is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: One hundred Thirty-sixth panel of table 3 E 0
  Fourth character (Body System / Region) is value P: Female Reproductive
  Fifth character (Approach) is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Substance) is value S: Gas
  Seventh character (Qualifier) is value F: Other Gas

No change: One hundred Thirty-seventh panel of table 3 E 0
  Fourth character (Body System / Region) is value Q: Cranial Cavity and Brain
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 3 choices.
    First choice is value 4: Liquid Brachytherapy Radioisotope
    Second choice is value 5: Other Antineoplastic
    Third choice is value M: Monoclonal Antibody

No change: One hundred Thirty-eighth panel of table 3 E 0
  Fourth character (Body System / Region) is value Q: Cranial Cavity and Brain
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

No change: One hundred Thirty-ninth panel of table 3 E 0
  Fourth character (Body System / Region) is value Q: Cranial Cavity and Brain
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
  Sixth character (Substance) has 9 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value 6: Nutritional Substance
    Third choice is value 7: Electrolytic and Water Balance Substance
    Fourth choice is value A: Stem Cells, Embryonic
    Fifth choice is value B: Anesthetic Agent
    Sixth choice is value H: Radioactive Substance
    Seventh choice is value K: Other Diagnostic Substance
    Eighth choice is value N: Analgesics, Hypnotics, Sedatives
    Ninth choice is value T: Destructive Agent
  Seventh character (Qualifier) is value Z: No Qualifier

No change: One hundred Fortieth panel of table 3 E 0
  Fourth character (Body System / Region) is value Q: Cranial Cavity and Brain
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
  Sixth character (Substance) is value E: Stem Cells, Somatic
  Seventh character (Qualifier) has 2 choices.
    First choice is value 0: Autologous
    Second choice is value 1: Nonautologous

No change: One hundred Forty-first panel of table 3 E 0
  Fourth character (Body System / Region) is value Q: Cranial Cavity and Brain
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: One hundred Forty-second panel of table 3 E 0
  Fourth character (Body System / Region) is value Q: Cranial Cavity and Brain
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
  Sixth character (Substance) is value S: Gas
  Seventh character (Qualifier) is value F: Other Gas

No change: One hundred Forty-third panel of table 3 E 0
  Fourth character (Body System / Region) is value Q: Cranial Cavity and Brain
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 3 choices.
    First choice is value 4: Liquid Brachytherapy Radioisotope
    Second choice is value 5: Other Antineoplastic
    Third choice is value M: Monoclonal Antibody

No change: One hundred Forty-fourth panel of table 3 E 0
  Fourth character (Body System / Region) is value Q: Cranial Cavity and Brain
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Substance) is value S: Gas
  Seventh character (Qualifier) is value F: Other Gas

No change: One hundred Forty-fifth panel of table 3 E 0
  Fourth character (Body System / Region) is value R: Spinal Canal
  Fifth character (Approach) is value 0: Open
  Sixth character (Substance) is value A: Stem Cells, Embryonic
  Seventh character (Qualifier) is value Z: No Qualifier

No change: One hundred Forty-sixth panel of table 3 E 0
  Fourth character (Body System / Region) is value R: Spinal Canal
  Fifth character (Approach) is value 0: Open
  Sixth character (Substance) is value E: Stem Cells, Somatic
  Seventh character (Qualifier) has 2 choices.
    First choice is value 0: Autologous
    Second choice is value 1: Nonautologous

No change: One hundred Forty-seventh panel of table 3 E 0
  Fourth character (Body System / Region) is value R: Spinal Canal
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 5 choices.
    First choice is value 2: High-dose Interleukin-2
    Second choice is value 3: Low-dose Interleukin-2
    Third choice is value 4: Liquid Brachytherapy Radioisotope
    Fourth choice is value 5: Other Antineoplastic
    Fifth choice is value M: Monoclonal Antibody

No change: One hundred Forty-eighth panel of table 3 E 0
  Fourth character (Body System / Region) is value R: Spinal Canal
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

No change: One hundred Forty-ninth panel of table 3 E 0
  Fourth character (Body System / Region) is value R: Spinal Canal
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) has 9 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value 6: Nutritional Substance
    Third choice is value 7: Electrolytic and Water Balance Substance
    Fourth choice is value A: Stem Cells, Embryonic
    Fifth choice is value B: Anesthetic Agent
    Sixth choice is value H: Radioactive Substance
    Seventh choice is value K: Other Diagnostic Substance
    Eighth choice is value N: Analgesics, Hypnotics, Sedatives
    Ninth choice is value T: Destructive Agent
  Seventh character (Qualifier) is value Z: No Qualifier

No change: One hundred Fiftieth panel of table 3 E 0
  Fourth character (Body System / Region) is value R: Spinal Canal
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value E: Stem Cells, Somatic
  Seventh character (Qualifier) has 2 choices.
    First choice is value 0: Autologous
    Second choice is value 1: Nonautologous

No change: One hundred Fifty-first panel of table 3 E 0
  Fourth character (Body System / Region) is value R: Spinal Canal
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: One hundred Fifty-second panel of table 3 E 0
  Fourth character (Body System / Region) is value R: Spinal Canal
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value S: Gas
  Seventh character (Qualifier) is value F: Other Gas

No change: One hundred Fifty-third panel of table 3 E 0
  Fourth character (Body System / Region) is value R: Spinal Canal
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Substance) is value S: Gas
  Seventh character (Qualifier) is value F: Other Gas

No change: One hundred Fifty-fourth panel of table 3 E 0
  Fourth character (Body System / Region) is value S: Epidural Space
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 5 choices.
    First choice is value 2: High-dose Interleukin-2
    Second choice is value 3: Low-dose Interleukin-2
    Third choice is value 4: Liquid Brachytherapy Radioisotope
    Fourth choice is value 5: Other Antineoplastic
    Fifth choice is value M: Monoclonal Antibody

No change: One hundred Fifty-fifth panel of table 3 E 0
  Fourth character (Body System / Region) is value S: Epidural Space
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

No change: One hundred Fifty-sixth panel of table 3 E 0
  Fourth character (Body System / Region) is value S: Epidural Space
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) has 8 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value 6: Nutritional Substance
    Third choice is value 7: Electrolytic and Water Balance Substance
    Fourth choice is value B: Anesthetic Agent
    Fifth choice is value H: Radioactive Substance
    Sixth choice is value K: Other Diagnostic Substance
    Seventh choice is value N: Analgesics, Hypnotics, Sedatives
    Eighth choice is value T: Destructive Agent
  Seventh character (Qualifier) is value Z: No Qualifier

No change: One hundred Fifty-seventh panel of table 3 E 0
  Fourth character (Body System / Region) is value S: Epidural Space
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: One hundred Fifty-eighth panel of table 3 E 0
  Fourth character (Body System / Region) is value S: Epidural Space
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value S: Gas
  Seventh character (Qualifier) is value F: Other Gas

No change: One hundred Fifty-ninth panel of table 3 E 0
  Fourth character (Body System / Region) is value S: Epidural Space
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Substance) is value S: Gas
  Seventh character (Qualifier) is value F: Other Gas

No change: One hundred Sixtieth panel of table 3 E 0
  Fourth character (Body System / Region) has 2 choices.
    First choice is value T: Peripheral Nerves and Plexi
    Second choice is value X: Cranial Nerves
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) has 3 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value B: Anesthetic Agent
    Third choice is value T: Destructive Agent
  Seventh character (Qualifier) is value Z: No Qualifier

No change: One hundred Sixty-first panel of table 3 E 0
  Fourth character (Body System / Region) has 2 choices.
    First choice is value T: Peripheral Nerves and Plexi
    Second choice is value X: Cranial Nerves
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: One hundred Sixty-second panel of table 3 E 0
  Fourth character (Body System / Region) is value U: Joints
  Fifth character (Approach) is value 0: Open
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

No change: One hundred Sixty-third panel of table 3 E 0
  Fourth character (Body System / Region) is value U: Joints
  Fifth character (Approach) is value 0: Open
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) has 2 choices.
    First choice is value B: Recombinant Bone Morphogenetic Protein
    Second choice is value C: Other Substance

No change: One hundred Sixty-fourth panel of table 3 E 0
  Fourth character (Body System / Region) is value U: Joints
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 3 choices.
    First choice is value 4: Liquid Brachytherapy Radioisotope
    Second choice is value 5: Other Antineoplastic
    Third choice is value M: Monoclonal Antibody

No change: One hundred Sixty-fifth panel of table 3 E 0
  Fourth character (Body System / Region) is value U: Joints
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

No change: One hundred Sixty-sixth panel of table 3 E 0
  Fourth character (Body System / Region) is value U: Joints
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) has 8 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value 6: Nutritional Substance
    Third choice is value 7: Electrolytic and Water Balance Substance
    Fourth choice is value B: Anesthetic Agent
    Fifth choice is value H: Radioactive Substance
    Sixth choice is value K: Other Diagnostic Substance
    Seventh choice is value N: Analgesics, Hypnotics, Sedatives
    Eighth choice is value T: Destructive Agent
  Seventh character (Qualifier) is value Z: No Qualifier

No change: One hundred Sixty-seventh panel of table 3 E 0
  Fourth character (Body System / Region) is value U: Joints
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) has 2 choices.
    First choice is value B: Recombinant Bone Morphogenetic Protein
    Second choice is value C: Other Substance

No change: One hundred Sixty-eighth panel of table 3 E 0
  Fourth character (Body System / Region) is value U: Joints
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value S: Gas
  Seventh character (Qualifier) is value F: Other Gas

No change: One hundred Sixty-ninth panel of table 3 E 0
  Fourth character (Body System / Region) is value U: Joints
  Fifth character (Approach) is value 4: Percutaneous Endoscopic
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: One hundred Seventieth panel of table 3 E 0
  Fourth character (Body System / Region) is value V: Bones
  Fifth character (Approach) is value 0: Open
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) has 2 choices.
    First choice is value B: Recombinant Bone Morphogenetic Protein
    Second choice is value C: Other Substance

No change: One hundred Seventy-first panel of table 3 E 0
  Fourth character (Body System / Region) is value V: Bones
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 2 choices.
    First choice is value 5: Other Antineoplastic
    Second choice is value M: Monoclonal Antibody

No change: One hundred Seventy-second panel of table 3 E 0
  Fourth character (Body System / Region) is value V: Bones
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

No change: One hundred Seventy-third panel of table 3 E 0
  Fourth character (Body System / Region) is value V: Bones
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) has 8 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value 6: Nutritional Substance
    Third choice is value 7: Electrolytic and Water Balance Substance
    Fourth choice is value B: Anesthetic Agent
    Fifth choice is value H: Radioactive Substance
    Sixth choice is value K: Other Diagnostic Substance
    Seventh choice is value N: Analgesics, Hypnotics, Sedatives
    Eighth choice is value T: Destructive Agent
  Seventh character (Qualifier) is value Z: No Qualifier

No change: One hundred Seventy-fourth panel of table 3 E 0
  Fourth character (Body System / Region) is value V: Bones
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) has 2 choices.
    First choice is value B: Recombinant Bone Morphogenetic Protein
    Second choice is value C: Other Substance

No change: One hundred Seventy-fifth panel of table 3 E 0
  Fourth character (Body System / Region) is value V: Bones
  Fifth character (Approach) is value 4: Percutaneous Endoscopic
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: One hundred Seventy-sixth panel of table 3 E 0
  Fourth character (Body System / Region) is value W: Lymphatics
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 2 choices.
    First choice is value 5: Other Antineoplastic
    Second choice is value M: Monoclonal Antibody

No change: One hundred Seventy-seventh panel of table 3 E 0
  Fourth character (Body System / Region) is value W: Lymphatics
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

No change: One hundred Seventy-eighth panel of table 3 E 0
  Fourth character (Body System / Region) is value W: Lymphatics
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) has 8 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value 6: Nutritional Substance
    Third choice is value 7: Electrolytic and Water Balance Substance
    Fourth choice is value B: Anesthetic Agent
    Fifth choice is value H: Radioactive Substance
    Sixth choice is value K: Other Diagnostic Substance
    Seventh choice is value N: Analgesics, Hypnotics, Sedatives
    Eighth choice is value T: Destructive Agent
  Seventh character (Qualifier) is value Z: No Qualifier

No change: One hundred Seventy-ninth panel of table 3 E 0
  Fourth character (Body System / Region) is value W: Lymphatics
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: One hundred Eightieth panel of table 3 E 0
  Fourth character (Body System / Region) is value Y: Pericardial Cavity
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 3 choices.
    First choice is value 4: Liquid Brachytherapy Radioisotope
    Second choice is value 5: Other Antineoplastic
    Third choice is value M: Monoclonal Antibody

No change: One hundred Eighty-first panel of table 3 E 0
  Fourth character (Body System / Region) is value Y: Pericardial Cavity
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value 2: Anti-infective
  Seventh character (Qualifier) has 2 choices.
    First choice is value 8: Oxazolidinones
    Second choice is value 9: Other Anti-infective

No change: One hundred Eighty-second panel of table 3 E 0
  Fourth character (Body System / Region) is value Y: Pericardial Cavity
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) has 8 choices.
    First choice is value 3: Anti-inflammatory
    Second choice is value 6: Nutritional Substance
    Third choice is value 7: Electrolytic and Water Balance Substance
    Fourth choice is value B: Anesthetic Agent
    Fifth choice is value H: Radioactive Substance
    Sixth choice is value K: Other Diagnostic Substance
    Seventh choice is value N: Analgesics, Hypnotics, Sedatives
    Eighth choice is value T: Destructive Agent
  Seventh character (Qualifier) is value Z: No Qualifier

No change: One hundred Eighty-third panel of table 3 E 0
  Fourth character (Body System / Region) is value Y: Pericardial Cavity
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: One hundred Eighty-fourth panel of table 3 E 0
  Fourth character (Body System / Region) is value Y: Pericardial Cavity
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Substance) is value S: Gas
  Seventh character (Qualifier) is value F: Other Gas

No change: One hundred Eighty-fifth panel of table 3 E 0
  Fourth character (Body System / Region) is value Y: Pericardial Cavity
  Fifth character (Approach) is value 4: Percutaneous Endoscopic
  Sixth character (Substance) is value G: Other Therapeutic Substance
  Seventh character (Qualifier) is value C: Other Substance

No change: One hundred Eighty-sixth panel of table 3 E 0
  Fourth character (Body System / Region) is value Y: Pericardial Cavity
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Substance) is value 0: Antineoplastic
  Seventh character (Qualifier) has 3 choices.
    First choice is value 4: Liquid Brachytherapy Radioisotope
    Second choice is value 5: Other Antineoplastic
    Third choice is value M: Monoclonal Antibody

No change: One hundred Eighty-seventh panel of table 3 E 0
  Fourth character (Body System / Region) is value Y: Pericardial Cavity
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Substance) is value S: Gas
  Seventh character (Qualifier) is value F: Other Gas

No change: table 4 A 0
  First character (Section) is value 4: Measurement and Monitoring
  Second character (Body System) is value A: Physiological Systems
  Third character (Operation) is value 0: Measurement: Determining the level of a physiological or physical function at a point in time

No change: First panel of table 4 A 0
  Fourth character (Body System) is value 0: Central Nervous
  Fifth character (Approach) is value 0: Open
  Sixth character (Function / Device) has 3 choices.
    First choice is value 2: Conductivity
    Second choice is value 4: Electrical Activity
    Third choice is value B: Pressure
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Second panel of table 4 A 0
  Fourth character (Body System) is value 0: Central Nervous
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Function / Device) is value 4: Electrical Activity
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Third panel of table 4 A 0
  Fourth character (Body System) is value 0: Central Nervous
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 7: Via Natural or Artificial Opening
    Third choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Function / Device) has 3 choices.
    First choice is value B: Pressure
    Second choice is value K: Temperature
    Third choice is value R: Saturation
  Seventh character (Qualifier) is value D: Intracranial

No change: Fourth panel of table 4 A 0
  Fourth character (Body System) is value 0: Central Nervous
  Fifth character (Approach) is value X: External
  Sixth character (Function / Device) has 2 choices.
    First choice is value 2: Conductivity
    Second choice is value 4: Electrical Activity
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Fifth panel of table 4 A 0
  Fourth character (Body System) is value 1: Peripheral Nervous
  Fifth character (Approach) has 5 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 7: Via Natural or Artificial Opening
    Fourth choice is value 8: Via Natural or Artificial Opening Endoscopic
    Fifth choice is value X: External
  Sixth character (Function / Device) is value 2: Conductivity
  Seventh character (Qualifier) has 2 choices.
    First choice is value 9: Sensory
    Second choice is value B: Motor

No change: Sixth panel of table 4 A 0
  Fourth character (Body System) is value 1: Peripheral Nervous
  Fifth character (Approach) has 5 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 7: Via Natural or Artificial Opening
    Fourth choice is value 8: Via Natural or Artificial Opening Endoscopic
    Fifth choice is value X: External
  Sixth character (Function / Device) is value 4: Electrical Activity
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Seventh panel of table 4 A 0
  Fourth character (Body System) is value 2: Cardiac
  Fifth character (Approach) has 4 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 7: Via Natural or Artificial Opening
    Fourth choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Function / Device) has 6 choices.
    First choice is value 4: Electrical Activity
    Second choice is value 9: Output
    Third choice is value C: Rate
    Fourth choice is value F: Rhythm
    Fifth choice is value H: Sound
    Sixth choice is value P: Action Currents
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Eighth panel of table 4 A 0
  Fourth character (Body System) is value 2: Cardiac
  Fifth character (Approach) has 4 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 7: Via Natural or Artificial Opening
    Fourth choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Function / Device) is value N: Sampling and Pressure
  Seventh character (Qualifier) has 3 choices.
    First choice is value 6: Right Heart
    Second choice is value 7: Left Heart
    Third choice is value 8: Bilateral

No change: Ninth panel of table 4 A 0
  Fourth character (Body System) is value 2: Cardiac
  Fifth character (Approach) is value X: External
  Sixth character (Function / Device) is value 4: Electrical Activity
  Seventh character (Qualifier) has 2 choices.
    First choice is value A: Guidance
    Second choice is value Z: No Qualifier

No change: Tenth panel of table 4 A 0
  Fourth character (Body System) is value 2: Cardiac
  Fifth character (Approach) is value X: External
  Sixth character (Function / Device) has 5 choices.
    First choice is value 9: Output
    Second choice is value C: Rate
    Third choice is value F: Rhythm
    Fourth choice is value H: Sound
    Fifth choice is value P: Action Currents
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Eleventh panel of table 4 A 0
  Fourth character (Body System) is value 2: Cardiac
  Fifth character (Approach) is value X: External
  Sixth character (Function / Device) is value M: Total Activity
  Seventh character (Qualifier) is value 4: Stress

No change: Twelfth panel of table 4 A 0
  Fourth character (Body System) is value 3: Arterial
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
  Sixth character (Function / Device) has 2 choices.
    First choice is value 5: Flow
    Second choice is value J: Pulse
  Seventh character (Qualifier) has 3 choices.
    First choice is value 1: Peripheral
    Second choice is value 3: Pulmonary
    Third choice is value C: Coronary

No change: Thirteenth panel of table 4 A 0
  Fourth character (Body System) is value 3: Arterial
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
  Sixth character (Function / Device) is value B: Pressure
  Seventh character (Qualifier) has 4 choices.
    First choice is value 1: Peripheral
    Second choice is value 3: Pulmonary
    Third choice is value C: Coronary
    Fourth choice is value F: Other Thoracic

No change: Fourteenth panel of table 4 A 0
  Fourth character (Body System) is value 3: Arterial
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
  Sixth character (Function / Device) has 2 choices.
    First choice is value H: Sound
    Second choice is value R: Saturation
  Seventh character (Qualifier) is value 1: Peripheral

No change: Fifteenth panel of table 4 A 0
  Fourth character (Body System) is value 3: Arterial
  Fifth character (Approach) is value X: External
  Sixth character (Function / Device) is value 5: Flow
  Seventh character (Qualifier) has 2 choices.
    First choice is value 1: Peripheral
    Second choice is value D: Intracranial

No change: Sixteenth panel of table 4 A 0
  Fourth character (Body System) is value 3: Arterial
  Fifth character (Approach) is value X: External
  Sixth character (Function / Device) has 4 choices.
    First choice is value B: Pressure
    Second choice is value H: Sound
    Third choice is value J: Pulse
    Fourth choice is value R: Saturation
  Seventh character (Qualifier) is value 1: Peripheral

No change: Seventeenth panel of table 4 A 0
  Fourth character (Body System) is value 4: Venous
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
  Sixth character (Function / Device) has 3 choices.
    First choice is value 5: Flow
    Second choice is value B: Pressure
    Third choice is value J: Pulse
  Seventh character (Qualifier) has 4 choices.
    First choice is value 0: Central
    Second choice is value 1: Peripheral
    Third choice is value 2: Portal
    Fourth choice is value 3: Pulmonary

No change: Eighteenth panel of table 4 A 0
  Fourth character (Body System) is value 4: Venous
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
  Sixth character (Function / Device) is value R: Saturation
  Seventh character (Qualifier) is value 1: Peripheral

No change: Nineteenth panel of table 4 A 0
  Fourth character (Body System) is value 4: Venous
  Fifth character (Approach) is value 4: Percutaneous Endoscopic
  Sixth character (Function / Device) is value B: Pressure
  Seventh character (Qualifier) is value 2: Portal

No change: Twentieth panel of table 4 A 0
  Fourth character (Body System) is value 4: Venous
  Fifth character (Approach) is value X: External
  Sixth character (Function / Device) has 4 choices.
    First choice is value 5: Flow
    Second choice is value B: Pressure
    Third choice is value J: Pulse
    Fourth choice is value R: Saturation
  Seventh character (Qualifier) is value 1: Peripheral

No change: Twenty-first panel of table 4 A 0
  Fourth character (Body System) is value 5: Circulatory
  Fifth character (Approach) is value X: External
  Sixth character (Function / Device) is value L: Volume
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Twenty-second panel of table 4 A 0
  Fourth character (Body System) is value 6: Lymphatic
  Fifth character (Approach) has 4 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 7: Via Natural or Artificial Opening
    Fourth choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Function / Device) has 2 choices.
    First choice is value 5: Flow
    Second choice is value B: Pressure
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Twenty-third panel of table 4 A 0
  Fourth character (Body System) is value 7: Visual
  Fifth character (Approach) is value X: External
  Sixth character (Function / Device) has 3 choices.
    First choice is value 0: Acuity
    Second choice is value 7: Mobility
    Third choice is value B: Pressure
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Twenty-fourth panel of table 4 A 0
  Fourth character (Body System) is value 8: Olfactory
  Fifth character (Approach) is value X: External
  Sixth character (Function / Device) is value 0: Acuity
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Twenty-fifth panel of table 4 A 0
  Fourth character (Body System) is value 9: Respiratory
  Fifth character (Approach) has 3 choices.
    First choice is value 7: Via Natural or Artificial Opening
    Second choice is value 8: Via Natural or Artificial Opening Endoscopic
    Third choice is value X: External
  Sixth character (Function / Device) has 6 choices.
    First choice is value 1: Capacity
    Second choice is value 5: Flow
    Third choice is value C: Rate
    Fourth choice is value D: Resistance
    Fifth choice is value L: Volume
    Sixth choice is value M: Total Activity
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Twenty-sixth panel of table 4 A 0
  Fourth character (Body System) is value B: Gastrointestinal
  Fifth character (Approach) has 2 choices.
    First choice is value 7: Via Natural or Artificial Opening
    Second choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Function / Device) has 3 choices.
    First choice is value 8: Motility
    Second choice is value B: Pressure
    Third choice is value G: Secretion
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Twenty-seventh panel of table 4 A 0
  Fourth character (Body System) is value C: Biliary
  Fifth character (Approach) has 4 choices.
    First choice is value 3: Percutaneous
    Second choice is value 4: Percutaneous Endoscopic
    Third choice is value 7: Via Natural or Artificial Opening
    Fourth choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Function / Device) has 2 choices.
    First choice is value 5: Flow
    Second choice is value B: Pressure
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Twenty-eighth panel of table 4 A 0
  Fourth character (Body System) is value D: Urinary
  Fifth character (Approach) has 2 choices.
    First choice is value 7: Via Natural or Artificial Opening
    Second choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Function / Device) has 5 choices.
    First choice is value 3: Contractility
    Second choice is value 5: Flow
    Third choice is value B: Pressure
    Fourth choice is value D: Resistance
    Fifth choice is value L: Volume
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Twenty-ninth panel of table 4 A 0
  Fourth character (Body System) is value F: Musculoskeletal
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Function / Device) is value 3: Contractility
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Thirtieth panel of table 4 A 0
  Fourth character (Body System) is value F: Musculoskeletal
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Function / Device) is value B: Pressure
  Seventh character (Qualifier) is value E: Compartment

No change: Thirty-first panel of table 4 A 0
  Fourth character (Body System) is value F: Musculoskeletal
  Fifth character (Approach) is value X: External
  Sixth character (Function / Device) is value 3: Contractility
  Seventh character (Qualifier) is value Z: No Qualifier

FY2026: Thirty-second panel of table 4 A 0
  Fourth character (Body System) is value F: Musculoskeletal
  Fifth character (Approach) is value X: External
  Sixth character (Function / Device) is value E: Body Composition
  Seventh character (Qualifier) is value J: Air Displacement Plethysmography

No change: Thirty-third panel of table 4 A 0
  Fourth character (Body System) is value H: Products of Conception, Cardiac
  Fifth character (Approach) has 3 choices.
    First choice is value 7: Via Natural or Artificial Opening
    Second choice is value 8: Via Natural or Artificial Opening Endoscopic
    Third choice is value X: External
  Sixth character (Function / Device) has 4 choices.
    First choice is value 4: Electrical Activity
    Second choice is value C: Rate
    Third choice is value F: Rhythm
    Fourth choice is value H: Sound
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Thirty-fourth panel of table 4 A 0
  Fourth character (Body System) is value J: Products of Conception, Nervous
  Fifth character (Approach) has 3 choices.
    First choice is value 7: Via Natural or Artificial Opening
    Second choice is value 8: Via Natural or Artificial Opening Endoscopic
    Third choice is value X: External
  Sixth character (Function / Device) has 3 choices.
    First choice is value 2: Conductivity
    Second choice is value 4: Electrical Activity
    Third choice is value B: Pressure
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Thirty-fifth panel of table 4 A 0
  Fourth character (Body System) is value Z: None
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Function / Device) has 2 choices.
    First choice is value 6: Metabolism
    Second choice is value K: Temperature
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Thirty-sixth panel of table 4 A 0
  Fourth character (Body System) is value Z: None
  Fifth character (Approach) is value X: External
  Sixth character (Function / Device) has 3 choices.
    First choice is value 6: Metabolism
    Second choice is value K: Temperature
    Third choice is value Q: Sleep
  Seventh character (Qualifier) is value Z: No Qualifier

No change: table 5 A 0
  First character (Section) is value 5: Extracorporeal or Systemic Assistance and Performance
  Second character (Body System) is value A: Physiological Systems
  Third character (Operation) is value 0: Assistance: Taking over a portion of a physiological function by extracorporeal means

No change: First panel of table 5 A 0
  Fourth character (Body System) is value 2: Cardiac
  Fifth character (Duration) is value 1: Intermittent
  Sixth character (Function) is value 1: Output
  Seventh character (Qualifier) has 4 choices.
    First choice is value 0: Balloon Pump
    Second choice is value 5: Pulsatile Compression
    Third choice is value 6: Other Pump
    Fourth choice is value D: Impeller Pump

FY2026: Second panel of table 5 A 0
  Fourth character (Body System) is value 2: Cardiac
  Fifth character (Duration) is value 2: Continuous
  Sixth character (Function) is value 1: Output
  Seventh character (Qualifier) has 5 choices.
    First choice is value 0: Balloon Pump
    Second choice is value 5: Pulsatile Compression
    Third choice is value 6: Other Pump
    Fourth choice is value D: Impeller Pump
    Fifth choice is value E: Blood Flow Modulator

No change: Third panel of table 5 A 0
  Fourth character (Body System) is value 2: Cardiac
  Fifth character (Duration) is value 2: Continuous
  Sixth character (Function) is value 2: Oxygenation
  Seventh character (Qualifier) is value C: Supersaturated

No change: Fourth panel of table 5 A 0
  Fourth character (Body System) is value 5: Circulatory
  Fifth character (Duration) has 2 choices.
    First choice is value 1: Intermittent
    Second choice is value 2: Continuous
  Sixth character (Function) is value 2: Oxygenation
  Seventh character (Qualifier) is value 1: Hyperbaric

No change: Fifth panel of table 5 A 0
  Fourth character (Body System) is value 5: Circulatory
  Fifth character (Duration) is value A: Intraoperative
  Sixth character (Function) is value 0: Filtration
  Seventh character (Qualifier) is value L: Peripheral Veno-venous

No change: Sixth panel of table 5 A 0
  Fourth character (Body System) is value 5: Circulatory
  Fifth character (Duration) is value A: Intraoperative
  Sixth character (Function) is value 6: Cerebral Embolic Filtration
  Seventh character (Qualifier) has 4 choices.
    First choice is value M: Single Capture Filter
    Second choice is value N: Dual Capture Filter
    Third choice is value P: Single Deflection Filter
    Fourth choice is value Q: Extracorporeal Flow Reversal Circuit

No change: Seventh panel of table 5 A 0
  Fourth character (Body System) is value 9: Respiratory
  Fifth character (Duration) is value 2: Continuous
  Sixth character (Function) is value 0: Filtration
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Eighth panel of table 5 A 0
  Fourth character (Body System) is value 9: Respiratory
  Fifth character (Duration) has 3 choices.
    First choice is value 3: Less than 24 Consecutive Hours
    Second choice is value 4: 24-96 Consecutive Hours
    Third choice is value 5: Greater than 96 Consecutive Hours
  Sixth character (Function) is value 5: Ventilation
  Seventh character (Qualifier) has 6 choices.
    First choice is value 7: Continuous Positive Airway Pressure
    Second choice is value 8: Intermittent Positive Airway Pressure
    Third choice is value 9: Continuous Negative Airway Pressure
    Fourth choice is value A: High Flow/Velocity Cannula
    Fifth choice is value B: Intermittent Negative Airway Pressure
    Sixth choice is value Z: No Qualifier

No change: Ninth panel of table 5 A 0
  Fourth character (Body System) is value 9: Respiratory
  Fifth character (Duration) has 3 choices.
    First choice is value B: Less than 8 Consecutive Hours
    Second choice is value C: 8-24 Consecutive Hours
    Third choice is value D: Greater than 24 Consecutive Hours
  Sixth character (Function) is value 5: Ventilation
  Seventh character (Qualifier) is value K: Intubated Prone Positioning

No change: table F 0 7
  First character (Section) is value F: Physical Rehabilitation and Diagnostic Audiology
  Second character (Section Qualifier) is value 0: Rehabilitation
  Third character (Type) is value 7: Motor Treatment: Exercise or activities to increase or facilitate motor function

FY2026: First panel of table F 0 7
  Fourth character (Body System / Region) has 8 choices.
    First choice is value 0: Neurological System - Head and Neck
    Second choice is value 1: Neurological System - Upper Back / Upper Extremity
    Third choice is value 2: Neurological System - Lower Back / Lower Extremity
    Fourth choice is value 3: Neurological System - Whole Body
    Fifth choice is value J: Musculoskeletal System - Head and Neck
    Sixth choice is value K: Musculoskeletal System - Upper Back / Upper Extremity
    Seventh choice is value L: Musculoskeletal System - Lower Back / Lower Extremity
    Eighth choice is value M: Musculoskeletal System - Whole Body
  Fifth character (Type Qualifier) has 4 choices.
    First choice is value 0: Range of Motion and Joint Mobility
    Second choice is value 1: Muscle Performance
    Third choice is value 2: Coordination/Dexterity
    Fourth choice is value 3: Motor Function
  Sixth character (Equipment) has 5 choices.
    First choice is value E: Orthosis
    Second choice is value F: Assistive, Adaptive, Supportive or Protective
    Third choice is value U: Prosthesis
    Fourth choice is value Y: Other Equipment
    Fifth choice is value Z: None
  Seventh character (Qualifier) is value Z: None

FY2026: Second panel of table F 0 7
  Fourth character (Body System / Region) has 8 choices.
    First choice is value 0: Neurological System - Head and Neck
    Second choice is value 1: Neurological System - Upper Back / Upper Extremity
    Third choice is value 2: Neurological System - Lower Back / Lower Extremity
    Fourth choice is value 3: Neurological System - Whole Body
    Fifth choice is value J: Musculoskeletal System - Head and Neck
    Sixth choice is value K: Musculoskeletal System - Upper Back / Upper Extremity
    Seventh choice is value L: Musculoskeletal System - Lower Back / Lower Extremity
    Eighth choice is value M: Musculoskeletal System - Whole Body
  Fifth character (Type Qualifier) is value 6: Therapeutic Exercise
  Sixth character (Equipment) has 10 choices.
    First choice is value B: Physical Agents
    Second choice is value C: Mechanical
    Third choice is value D: Electrotherapeutic
    Fourth choice is value E: Orthosis
    Fifth choice is value F: Assistive, Adaptive, Supportive or Protective
    Sixth choice is value G: Aerobic Endurance and Conditioning
    Seventh choice is value H: Mechanical or Electromechanical
    Eighth choice is value U: Prosthesis
    Ninth choice is value Y: Other Equipment
    Tenth choice is value Z: None
  Seventh character (Qualifier) is value Z: None

FY2026: Third panel of table F 0 7
  Fourth character (Body System / Region) has 8 choices.
    First choice is value 0: Neurological System - Head and Neck
    Second choice is value 1: Neurological System - Upper Back / Upper Extremity
    Third choice is value 2: Neurological System - Lower Back / Lower Extremity
    Fourth choice is value 3: Neurological System - Whole Body
    Fifth choice is value J: Musculoskeletal System - Head and Neck
    Sixth choice is value K: Musculoskeletal System - Upper Back / Upper Extremity
    Seventh choice is value L: Musculoskeletal System - Lower Back / Lower Extremity
    Eighth choice is value M: Musculoskeletal System - Whole Body
  Fifth character (Type Qualifier) is value 7: Manual Therapy Techniques
  Sixth character (Equipment) is value Z: None
  Seventh character (Qualifier) is value Z: None

No change: Fourth panel of table F 0 7
  Fourth character (Body System / Region) has 8 choices.
    First choice is value 4: Circulatory System - Head and Neck
    Second choice is value 5: Circulatory System - Upper Back / Upper Extremity
    Third choice is value 6: Circulatory System - Lower Back / Lower Extremity
    Fourth choice is value 7: Circulatory System - Whole Body
    Fifth choice is value 8: Respiratory System - Head and Neck
    Sixth choice is value 9: Respiratory System - Upper Back / Upper Extremity
    Seventh choice is value B: Respiratory System - Lower Back / Lower Extremity
    Eighth choice is value C: Respiratory System - Whole Body
  Fifth character (Type Qualifier) is value 6: Therapeutic Exercise
  Sixth character (Equipment) has 10 choices.
    First choice is value B: Physical Agents
    Second choice is value C: Mechanical
    Third choice is value D: Electrotherapeutic
    Fourth choice is value E: Orthosis
    Fifth choice is value F: Assistive, Adaptive, Supportive or Protective
    Sixth choice is value G: Aerobic Endurance and Conditioning
    Seventh choice is value H: Mechanical or Electromechanical
    Eighth choice is value U: Prosthesis
    Ninth choice is value Y: Other Equipment
    Tenth choice is value Z: None
  Seventh character (Qualifier) is value Z: None

FY2026: Fifth panel of table F 0 7
  Fourth character (Body System / Region) has 4 choices.
    First choice is value D: Integumentary System - Head and Neck
    Second choice is value F: Integumentary System - Upper Back / Upper Extremity
    Third choice is value G: Integumentary System - Lower Back / Lower Extremity
    Fourth choice is value H: Integumentary System - Whole Body
  Fifth character (Type Qualifier) has 4 choices.
    First choice is value 0: Range of Motion and Joint Mobility
    Second choice is value 1: Muscle Performance
    Third choice is value 2: Coordination/Dexterity
    Fourth choice is value 3: Motor Function
  Sixth character (Equipment) has 5 choices.
    First choice is value E: Orthosis
    Second choice is value F: Assistive, Adaptive, Supportive or Protective
    Third choice is value U: Prosthesis
    Fourth choice is value Y: Other Equipment
    Fifth choice is value Z: None
  Seventh character (Qualifier) is value Z: None

FY2026: Sixth panel of table F 0 7
  Fourth character (Body System / Region) has 4 choices.
    First choice is value D: Integumentary System - Head and Neck
    Second choice is value F: Integumentary System - Upper Back / Upper Extremity
    Third choice is value G: Integumentary System - Lower Back / Lower Extremity
    Fourth choice is value H: Integumentary System - Whole Body
  Fifth character (Type Qualifier) is value 6: Therapeutic Exercise
  Sixth character (Equipment) has 10 choices.
    First choice is value B: Physical Agents
    Second choice is value C: Mechanical
    Third choice is value D: Electrotherapeutic
    Fourth choice is value E: Orthosis
    Fifth choice is value F: Assistive, Adaptive, Supportive or Protective
    Sixth choice is value G: Aerobic Endurance and Conditioning
    Seventh choice is value H: Mechanical or Electromechanical
    Eighth choice is value U: Prosthesis
    Ninth choice is value Y: Other Equipment
    Tenth choice is value Z: None
  Seventh character (Qualifier) is value Z: None

FY2026: Seventh panel of table F 0 7
  Fourth character (Body System / Region) has 4 choices.
    First choice is value D: Integumentary System - Head and Neck
    Second choice is value F: Integumentary System - Upper Back / Upper Extremity
    Third choice is value G: Integumentary System - Lower Back / Lower Extremity
    Fourth choice is value H: Integumentary System - Whole Body
  Fifth character (Type Qualifier) is value 7: Manual Therapy Techniques
  Sixth character (Equipment) is value Z: None
  Seventh character (Qualifier) is value Z: None

FY2026: Eighth panel of table F 0 7
  Fourth character (Body System / Region) has 4 choices.
    First choice is value D: Integumentary System - Head and Neck
    Second choice is value F: Integumentary System - Upper Back / Upper Extremity
    Third choice is value G: Integumentary System - Lower Back / Lower Extremity
    Fourth choice is value H: Integumentary System - Whole Body
  Fifth character (Type Qualifier) is value Y: Other Therapy Techniques
  Sixth character (Equipment) is value D: Electrotherapeutic
  Seventh character (Qualifier) is value 0: Microcurrent Stimulation

FY2026: Ninth panel of table F 0 7
  Fourth character (Body System / Region) is value E: Integumentary System - Thorax / Abdomen
  Fifth character (Type Qualifier) is value Y: Other Therapy Techniques
  Sixth character (Equipment) is value D: Electrotherapeutic
  Seventh character (Qualifier) is value 0: Microcurrent Stimulation

No change: Tenth panel of table F 0 7
  Fourth character (Body System / Region) is value N: Genitourinary System
  Fifth character (Type Qualifier) is value 1: Muscle Performance
  Sixth character (Equipment) has 5 choices.
    First choice is value E: Orthosis
    Second choice is value F: Assistive, Adaptive, Supportive or Protective
    Third choice is value U: Prosthesis
    Fourth choice is value Y: Other Equipment
    Fifth choice is value Z: None
  Seventh character (Qualifier) is value Z: None

No change: Eleventh panel of table F 0 7
  Fourth character (Body System / Region) is value N: Genitourinary System
  Fifth character (Type Qualifier) is value 6: Therapeutic Exercise
  Sixth character (Equipment) has 10 choices.
    First choice is value B: Physical Agents
    Second choice is value C: Mechanical
    Third choice is value D: Electrotherapeutic
    Fourth choice is value E: Orthosis
    Fifth choice is value F: Assistive, Adaptive, Supportive or Protective
    Sixth choice is value G: Aerobic Endurance and Conditioning
    Seventh choice is value H: Mechanical or Electromechanical
    Eighth choice is value U: Prosthesis
    Ninth choice is value Y: Other Equipment
    Tenth choice is value Z: None
  Seventh character (Qualifier) is value Z: None

No change: Twelfth panel of table F 0 7
  Fourth character (Body System / Region) is value Z: None
  Fifth character (Type Qualifier) is value 4: Wheelchair Mobility
  Sixth character (Equipment) has 6 choices.
    First choice is value D: Electrotherapeutic
    Second choice is value E: Orthosis
    Third choice is value F: Assistive, Adaptive, Supportive or Protective
    Fourth choice is value U: Prosthesis
    Fifth choice is value Y: Other Equipment
    Sixth choice is value Z: None
  Seventh character (Qualifier) is value Z: None

No change: Thirteenth panel of table F 0 7
  Fourth character (Body System / Region) is value Z: None
  Fifth character (Type Qualifier) is value 5: Bed Mobility
  Sixth character (Equipment) has 6 choices.
    First choice is value C: Mechanical
    Second choice is value E: Orthosis
    Third choice is value F: Assistive, Adaptive, Supportive or Protective
    Fourth choice is value U: Prosthesis
    Fifth choice is value Y: Other Equipment
    Sixth choice is value Z: None
  Seventh character (Qualifier) is value Z: None

No change: Fourteenth panel of table F 0 7
  Fourth character (Body System / Region) is value Z: None
  Fifth character (Type Qualifier) is value 8: Transfer Training
  Sixth character (Equipment) has 7 choices.
    First choice is value C: Mechanical
    Second choice is value D: Electrotherapeutic
    Third choice is value E: Orthosis
    Fourth choice is value F: Assistive, Adaptive, Supportive or Protective
    Fifth choice is value U: Prosthesis
    Sixth choice is value Y: Other Equipment
    Seventh choice is value Z: None
  Seventh character (Qualifier) is value Z: None

No change: Fifteenth panel of table F 0 7
  Fourth character (Body System / Region) is value Z: None
  Fifth character (Type Qualifier) is value 9: Gait Training/Functional Ambulation
  Sixth character (Equipment) has 8 choices.
    First choice is value C: Mechanical
    Second choice is value D: Electrotherapeutic
    Third choice is value E: Orthosis
    Fourth choice is value F: Assistive, Adaptive, Supportive or Protective
    Fifth choice is value G: Aerobic Endurance and Conditioning
    Sixth choice is value U: Prosthesis
    Seventh choice is value Y: Other Equipment
    Eighth choice is value Z: None
  Seventh character (Qualifier) is value Z: None

No change: table F 0 8
  First character (Section) is value F: Physical Rehabilitation and Diagnostic Audiology
  Second character (Section Qualifier) is value 0: Rehabilitation
  Third character (Type) is value 8: Activities of Daily Living Treatment: Exercise or activities to facilitate functional competence for activities of daily living

FY2026: First panel of table F 0 8
  Fourth character (Body System / Region) has 10 choices.
    First choice is value D: Integumentary System - Head and Neck
    Second choice is value E: Integumentary System - Thorax / Abdomen
    Third choice is value F: Integumentary System - Upper Back / Upper Extremity
    Fourth choice is value G: Integumentary System - Lower Back / Lower Extremity
    Fifth choice is value H: Integumentary System - Whole Body
    Sixth choice is value J: Musculoskeletal System - Head and Neck
    Seventh choice is value K: Musculoskeletal System - Upper Back / Upper Extremity
    Eighth choice is value L: Musculoskeletal System - Lower Back / Lower Extremity
    Ninth choice is value M: Musculoskeletal System - Whole Body
    Tenth choice is value P: Musculoskeletal System - Thorax / Abdomen
  Fifth character (Type Qualifier) is value 5: Wound Management
  Sixth character (Equipment) has 9 choices.
    First choice is value A: Negative Pressure Therapy
    Second choice is value B: Physical Agents
    Third choice is value C: Mechanical
    Fourth choice is value D: Electrotherapeutic
    Fifth choice is value E: Orthosis
    Sixth choice is value F: Assistive, Adaptive, Supportive or Protective
    Seventh choice is value U: Prosthesis
    Eighth choice is value Y: Other Equipment
    Ninth choice is value Z: None
  Seventh character (Qualifier) is value Z: None

No change: Second panel of table F 0 8
  Fourth character (Body System / Region) is value Z: None
  Fifth character (Type Qualifier) has 3 choices.
    First choice is value 0: Bathing/Showering Techniques
    Second choice is value 1: Dressing Techniques
    Third choice is value 2: Grooming/Personal Hygiene
  Sixth character (Equipment) has 5 choices.
    First choice is value E: Orthosis
    Second choice is value F: Assistive, Adaptive, Supportive or Protective
    Third choice is value U: Prosthesis
    Fourth choice is value Y: Other Equipment
    Fifth choice is value Z: None
  Seventh character (Qualifier) is value Z: None

No change: Third panel of table F 0 8
  Fourth character (Body System / Region) is value Z: None
  Fifth character (Type Qualifier) is value 3: Feeding/Eating
  Sixth character (Equipment) has 7 choices.
    First choice is value C: Mechanical
    Second choice is value D: Electrotherapeutic
    Third choice is value E: Orthosis
    Fourth choice is value F: Assistive, Adaptive, Supportive or Protective
    Fifth choice is value U: Prosthesis
    Sixth choice is value Y: Other Equipment
    Seventh choice is value Z: None
  Seventh character (Qualifier) is value Z: None

No change: Fourth panel of table F 0 8
  Fourth character (Body System / Region) is value Z: None
  Fifth character (Type Qualifier) is value 4: Home Management
  Sixth character (Equipment) has 6 choices.
    First choice is value D: Electrotherapeutic
    Second choice is value E: Orthosis
    Third choice is value F: Assistive, Adaptive, Supportive or Protective
    Fourth choice is value U: Prosthesis
    Fifth choice is value Y: Other Equipment
    Sixth choice is value Z: None
  Seventh character (Qualifier) is value Z: None

No change: Fifth panel of table F 0 8
  Fourth character (Body System / Region) is value Z: None
  Fifth character (Type Qualifier) is value 6: Psychosocial Skills
  Sixth character (Equipment) is value Z: None
  Seventh character (Qualifier) is value Z: None

No change: Sixth panel of table F 0 8
  Fourth character (Body System / Region) is value Z: None
  Fifth character (Type Qualifier) is value 7: Vocational Activities and Functional Community or Work Reintegration Skills
  Sixth character (Equipment) has 9 choices.
    First choice is value B: Physical Agents
    Second choice is value C: Mechanical
    Third choice is value D: Electrotherapeutic
    Fourth choice is value E: Orthosis
    Fifth choice is value F: Assistive, Adaptive, Supportive or Protective
    Sixth choice is value G: Aerobic Endurance and Conditioning
    Seventh choice is value U: Prosthesis
    Eighth choice is value Y: Other Equipment
    Ninth choice is value Z: None
  Seventh character (Qualifier) is value Z: None

No change: table X 2 7
  First character (Section) is value X: New Technology
  Second character (Body System) is value 2: Cardiovascular System
  Third character (Operation) is value 7: Dilation: Expanding an orifice or the lumen of a tubular body part

FY2026: First panel of table X 2 7
  Fourth character (Body Part) is value 2: Inferior Vena Cava and Iliocaval Confluence
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value C: Intraluminal Device, Open-structure Polymer Lattice
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: Second panel of table X 2 7
  Fourth character (Body Part) has 2 choices.
    First choice is value 3: Pulmonary Artery, Right
    Second choice is value 4: Pulmonary Artery, Left
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 9: Intraluminal Device, Expandable
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: Third panel of table X 2 7
  Fourth character (Body Part) has 10 choices.
    First choice is value 5: Subclavian Vein, Right
    Second choice is value 6: Subclavian Vein, Left
    Third choice is value 7: Axillary Vein, Right
    Fourth choice is value 8: Axillary Vein, Left
    Fifth choice is value 9: Brachial Vein, Right
    Sixth choice is value A: Brachial Vein, Left
    Seventh choice is value B: Basilic Vein, Right
    Eighth choice is value C: Basilic Vein, Left
    Ninth choice is value D: Cephalic Vein, Right
    Tenth choice is value E: Cephalic Vein, Left
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 5: Intraluminal Device, Cell Impermeable
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: Fourth panel of table X 2 7
  Fourth character (Body Part) has 6 choices.
    First choice is value P: Anterior Tibial Artery, Right
    Second choice is value Q: Anterior Tibial Artery, Left
    Third choice is value R: Posterior Tibial Artery, Right
    Fourth choice is value S: Posterior Tibial Artery, Left
    Fifth choice is value T: Peroneal Artery, Right
    Sixth choice is value U: Peroneal Artery, Left
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value T: Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s)
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Fifth panel of table X 2 7
  Fourth character (Body Part) has 2 choices.
    First choice is value W: Thoracic Aorta, Descending
    Second choice is value X: Thoracic Aorta, Ascending/Arch
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 9: Intraluminal Device, Expandable
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: table X 2 H
  First character (Section) is value X: New Technology
  Second character (Body System) is value 2: Cardiovascular System
  Third character (Operation) is value H: Insertion: Putting in a nonbiological appliance that monitors, assists, performs, or prevents a physiological function but does not physically take the place of a body part

No change: First panel of table X 2 H
  Fourth character (Body Part) is value 0: Inferior Vena Cava
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value B: Volume Sensor Management Device
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: Second panel of table X 2 H
  Fourth character (Body Part) has 2 choices.
    First choice is value 0: Inferior Vena Cava
    Second choice is value 1: Superior Vena Cava
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value R: Intraluminal Device, Bioprosthetic Valve
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: Third panel of table X 2 H
  Fourth character (Body Part) is value 1: Superior Vena Cava
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value X: Temporary Phrenic Nerve/Diaphragm Stimulation Electrodes
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: Fourth panel of table X 2 H
  Fourth character (Body Part) has 2 choices.
    First choice is value 2: Femoral Vein, Right
    Second choice is value 3: Femoral Vein, Left
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value R: Intraluminal Device, Bioprosthetic Valve
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: Fifth panel of table X 2 H
  Fourth character (Body Part) has 2 choices.
    First choice is value 6: Atrium, Right
    Second choice is value K: Ventricle, Right
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value V: Intracardiac Pacemaker, Dual-Chamber
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: Sixth panel of table X 2 H
  Fourth character (Body Part) has 2 choices.
    First choice is value L: Axillary Artery, Right
    Second choice is value M: Axillary Artery, Left
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value F: Conduit to Short-term External Heart Assist System
  Seventh character (Qualifier) is value 9: New Technology Group 9

FY2026: Seventh panel of table X 2 H
  Fourth character (Body Part) has 2 choices.
    First choice is value M: Ventricular Septum
    Second choice is value V: Ventricle, Right
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value G: Defibrillator Lead, Lumenless Small-diameter
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: Eighth panel of table X 2 H
  Fourth character (Body Part) is value N: Ventricle, Left
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 7: Endocardiac Pacing Electrode
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: Ninth panel of table X 2 H
  Fourth character (Body Part) has 6 choices.
    First choice is value P: Anterior Tibial Artery, Right
    Second choice is value Q: Anterior Tibial Artery, Left
    Third choice is value R: Posterior Tibial Artery, Right
    Fourth choice is value S: Posterior Tibial Artery, Left
    Fifth choice is value T: Peroneal Artery, Right
    Sixth choice is value U: Peroneal Artery, Left
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 8: Intraluminal Device, Temporary
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: Tenth panel of table X 2 H
  Fourth character (Body Part) is value X: Thoracic Aorta, Ascending
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value F: Conduit to Short-term External Heart Assist System
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: table X 2 K
  First character (Section) is value X: New Technology
  Second character (Body System) is value 2: Cardiovascular System
  Third character (Operation) is value K: Bypass: Altering the route of passage of the contents of a tubular body part

FY2026: First panel of table X 2 K
  Fourth character (Body Part) is value 0: Inferior Vena Cava
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value F: Autologous Cell Seeded Tissue Engineered Resorbable Scaffold to Pulmonary Artery
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: Second panel of table X 2 K
  Fourth character (Body Part) is value A: Atrium, Left
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 0: Conduit through Coronary Sinus to Right Atrium
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Third panel of table X 2 K
  Fourth character (Body Part) has 2 choices.
    First choice is value B: Radial Artery, Right
    Second choice is value C: Radial Artery, Left
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 1: Thermal Resistance Energy
  Seventh character (Qualifier) is value 7: New Technology Group 7

FY2026: Fourth panel of table X 2 K
  Fourth character (Body Part) is value G: Hepatic Vein
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value F: Autologous Cell Seeded Tissue Engineered Resorbable Scaffold to Pulmonary Artery
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: Fifth panel of table X 2 K
  Fourth character (Body Part) has 2 choices.
    First choice is value H: Femoral Artery, Right
    Second choice is value J: Femoral Artery, Left
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value D: Conduit through Femoral Vein to Superficial Femoral Artery
    Second choice is value E: Conduit through Femoral Vein to Popliteal Artery
  Seventh character (Qualifier) is value 9: New Technology Group 9

FY2026: table X 9 H
  First character (Section) is value X: New Technology
  Second character (Body System) is value 9: Ear, Nose, Sinus
  Third character (Operation) is value H: Insertion: Putting in a nonbiological appliance that monitors, assists, performs, or prevents a physiological function but does not physically take the place of a body part

FY2026: First panel of table X 9 H
  Fourth character (Body Part) has 3 choices.
    First choice is value D: Inner Ear, Right
    Second choice is value E: Inner Ear, Left
    Third choice is value F: Inner Ear, Bilateral
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value 1: Infusion Device, Temporary
  Seventh character (Qualifier) is value B: New Technology Group 11

FY2026: table X U 7
  First character (Section) is value X: New Technology
  Second character (Body System) is value U: Female Reproductive System
  Third character (Operation) is value 7: Dilation: Expanding an orifice or the lumen of a tubular body part

FY2026: First panel of table X U 7
  Fourth character (Body Part) is value G: Vagina
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Device / Substance / Technology) is value 1: Intraluminal Device, Temporary Electromechanical
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: table X W 0
  First character (Section) is value X: New Technology
  Second character (Body System) is value W: Anatomical Regions
  Third character (Operation) is value 0: Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

No change: First panel of table X W 0
  Fourth character (Body Part) is value 0: Skin
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value 2: Anacaulase-bcdb
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Second panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 1: Daratumumab and Hyaluronidase-fihj
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Third panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 2: Talquetamab Antineoplastic
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: Fourth panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 4: Teclistamab Antineoplastic
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Fifth panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 6: Dasiglucagon
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Sixth panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 9: Satralizumab-mwge
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Seventh panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value F: Other New Technology Therapeutic Substance
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: Eighth panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 3 choices.
    First choice is value G: REGN-COV2 Monoclonal Antibody
    Second choice is value H: Other New Technology Monoclonal Antibody
    Third choice is value K: Leronlimab Monoclonal Antibody
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Ninth panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value L: Elranatamab Antineoplastic
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: Tenth panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value S: COVID-19 Vaccine Dose 1
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Eleventh panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value S: Epcoritamab Monoclonal Antibody
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: Twelfth panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value T: COVID-19 Vaccine Dose 2
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Thirteenth panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value T: Rozanolixizumab-noli Monoclonal Antibody
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: Fourteenth panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value U: COVID-19 Vaccine
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Fifteenth panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value V: COVID-19 Vaccine Dose 3
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Sixteenth panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value W: Caplacizumab
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: Seventeenth panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value W: COVID-19 Vaccine Booster
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Eighteenth panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value 2: Anacaulase-bcdb
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Nineteenth panel of table X W 0
  Fourth character (Body Part) is value 2: Muscle
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value D: Engineered Allogeneic Thymus Tissue
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Twentieth panel of table X W 0
  Fourth character (Body Part) is value 2: Muscle
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 3 choices.
    First choice is value S: COVID-19 Vaccine Dose 1
    Second choice is value T: COVID-19 Vaccine Dose 2
    Third choice is value U: COVID-19 Vaccine
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Twenty-first panel of table X W 0
  Fourth character (Body Part) is value 2: Muscle
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 4 choices.
    First choice is value V: COVID-19 Vaccine Dose 3
    Second choice is value W: COVID-19 Vaccine Booster
    Third choice is value X: Tixagevimab and Cilgavimab Monoclonal Antibody
    Fourth choice is value Y: Other New Technology Monoclonal Antibody
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Twenty-second panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 0: Spesolimab Monoclonal Antibody
  Seventh character (Qualifier) is value 8: New Technology Group 8

FY2026: Twenty-third panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value 0: Alpha1-proteinase Inhibitor
    Second choice is value 1: Anitocabtagene Autoleucel Immunotherapy
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: Twenty-fourth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value 3: Bentracimab, Ticagrelor Reversal Agent
    Second choice is value 4: Cefepime-taniborbactam Anti-infective
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Twenty-fifth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 5: Narsoplimab Monoclonal Antibody
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Twenty-sixth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 5: Mosunetuzumab Antineoplastic
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Twenty-seventh panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 5: Ceftobiprole Medocaril Anti-infective
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Twenty-eighth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 6: Terlipressin
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Twenty-ninth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 6: Afamitresgene Autoleucel Immunotherapy
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Thirtieth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 7: Coagulation Factor Xa, Inactivated
  Seventh character (Qualifier) is value 2: New Technology Group 2

No change: Thirty-first panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 7: Trilaciclib
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Thirty-second panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 7: Tabelecleucel Immunotherapy
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Thirty-third panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 8: Lurbinectedin
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Thirty-fourth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 8: Treosulfan
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Thirty-fifth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 8: Obecabtagene Autoleucel
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Thirty-sixth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 9: Ceftolozane/Tazobactam Anti-infective
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Thirty-seventh panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 9: Inebilizumab-cdon
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Thirty-eighth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 9: Odronextamab Antineoplastic
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Thirty-ninth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value A: Ciltacabtagene Autoleucel
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Fortieth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value B: Cytarabine and Daunorubicin Liposome Antineoplastic
  Seventh character (Qualifier) is value 3: New Technology Group 3

No change: Forty-first panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value B: Amivantamab Monoclonal Antibody
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Forty-second panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value B: Orca-T Allogeneic T-cell Immunotherapy
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Forty-third panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value C: Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Forty-fourth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value C: Zanidatamab Antineoplastic
    Second choice is value D: Donislecel-jujn Allogeneic Pancreatic Islet Cellular Suspension
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Forty-fifth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value E: Remdesivir Anti-infective
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: Forty-sixth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value F: Other New Technology Therapeutic Substance
  Seventh character (Qualifier) is value 3: New Technology Group 3

No change: Forty-seventh panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value F: Other New Technology Therapeutic Substance
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: Forty-eighth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value F: Non-Chimeric Antigen Receptor T-cell Immune Effector Cell Therapy
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Forty-ninth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value F: Valoctocogene Roxaparvovec-rvox
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: Fiftieth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value G: Sarilumab
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: Fifty-first panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value G: REGN-COV2 Monoclonal Antibody
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Fifty-second panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value G: Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Fifty-third panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value H: Tocilizumab
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: Fifty-fourth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value H: Other New Technology Monoclonal Antibody
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Fifty-fifth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 3 choices.
    First choice is value H: Axicabtagene Ciloleucel Immunotherapy
    Second choice is value J: Tisagenlecleucel Immunotherapy
    Third choice is value K: Idecabtagene Vicleucel Immunotherapy
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Fifty-sixth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value K: Sulbactam-Durlobactam
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: Fifty-seventh panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value L: CD24Fc Immunomodulator
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Fifty-eighth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value L: Lifileucel Immunotherapy
    Second choice is value M: Brexucabtagene Autoleucel Immunotherapy
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Fifty-ninth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value M: Emapalumab-lzsg Anti-IFNy Monoclonal Antibody
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Sixtieth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value N: Lisocabtagene Maraleucel Immunotherapy
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Sixty-first panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value N: Tarlatamab-dlle Antineoplastic
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Sixty-second panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value P: Glofitamab Antineoplastic
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: Sixty-third panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value P: Aztreonam-avibactam Anti-infective
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: Sixty-fourth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value Q: Tagraxofusp-erzs Antineoplastic
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: Sixty-fifth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value Q: Posoleucel
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: Sixty-sixth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value Q: Iloprost
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: Sixty-seventh panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value R: Rezafungin
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: Sixty-eighth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value R: Letetresgene Autoleucel
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: Sixty-ninth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value S: Iobenguane I-131 Antineoplastic
    Second choice is value W: Caplacizumab
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: Seventieth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value W: Fosfomycin Anti-infective
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: Seventy-first panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 0: Spesolimab Monoclonal Antibody
  Seventh character (Qualifier) is value 8: New Technology Group 8

FY2026: Seventy-second panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value 0: Alpha1-proteinase Inhibitor
    Second choice is value 1: Anitocabtagene Autoleucel Immunotherapy
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: Seventy-third panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value 3: Bentracimab, Ticagrelor Reversal Agent
    Second choice is value 4: Cefepime-taniborbactam Anti-infective
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Seventy-fourth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 5: Narsoplimab Monoclonal Antibody
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Seventy-fifth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 5: Mosunetuzumab Antineoplastic
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Seventy-sixth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 5: Ceftobiprole Medocaril Anti-infective
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Seventy-seventh panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 6: Terlipressin
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Seventy-eighth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 6: Afamitresgene Autoleucel Immunotherapy
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Seventy-ninth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 7: Coagulation Factor Xa, Inactivated
  Seventh character (Qualifier) is value 2: New Technology Group 2

No change: Eightieth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 7: Trilaciclib
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Eighty-first panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 7: Tabelecleucel Immunotherapy
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Eighty-second panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 8: Lurbinectedin
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Eighty-third panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 8: Treosulfan
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Eighty-fourth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 8: Obecabtagene Autoleucel
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Eighty-fifth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 9: Ceftolozane/Tazobactam Anti-infective
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Eighty-sixth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 9: Inebilizumab-cdon
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Eighty-seventh panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 9: Odronextamab Antineoplastic
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Eighty-eighth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value A: Ciltacabtagene Autoleucel
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Eighty-ninth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value B: Cytarabine and Daunorubicin Liposome Antineoplastic
  Seventh character (Qualifier) is value 3: New Technology Group 3

No change: Ninetieth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value B: Amivantamab Monoclonal Antibody
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Ninety-first panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value B: Orca-T Allogeneic T-cell Immunotherapy
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Ninety-second panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value C: Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Ninety-third panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value C: Zanidatamab Antineoplastic
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Ninety-fourth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value E: Remdesivir Anti-infective
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: Ninety-fifth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value F: Other New Technology Therapeutic Substance
  Seventh character (Qualifier) is value 3: New Technology Group 3

No change: Ninety-sixth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value F: Other New Technology Therapeutic Substance
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: Ninety-seventh panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value F: Non-Chimeric Antigen Receptor T-cell Immune Effector Cell Therapy
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Ninety-eighth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value F: Valoctocogene Roxaparvovec-rvox
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: Ninety-ninth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value G: Sarilumab
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: One hundredth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value G: REGN-COV2 Monoclonal Antibody
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: One hundred First panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value G: Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: One hundred Second panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value H: Tocilizumab
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: One hundred Third panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value H: Other New Technology Monoclonal Antibody
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: One hundred Fourth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 3 choices.
    First choice is value H: Axicabtagene Ciloleucel Immunotherapy
    Second choice is value J: Tisagenlecleucel Immunotherapy
    Third choice is value K: Idecabtagene Vicleucel Immunotherapy
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: One hundred Fifth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value K: Sulbactam-Durlobactam
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: One hundred Sixth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value L: CD24Fc Immunomodulator
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: One hundred Seventh panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value L: Lifileucel Immunotherapy
    Second choice is value M: Brexucabtagene Autoleucel Immunotherapy
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: One hundred Eighth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value M: Emapalumab-lzsg Anti-IFNy Monoclonal Antibody
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: One hundred Ninth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value N: Lisocabtagene Maraleucel Immunotherapy
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: One hundred Tenth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value N: Tarlatamab-dlle Antineoplastic
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: One hundred Eleventh panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value P: Glofitamab Antineoplastic
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: One hundred Twelfth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value P: Aztreonam-avibactam Anti-infective
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: One hundred Thirteenth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value Q: Tagraxofusp-erzs Antineoplastic
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: One hundred Fourteenth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value Q: Posoleucel
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: One hundred Fifteenth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value Q: Iloprost
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: One hundred Sixteenth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value R: Rezafungin
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: One hundred Seventeenth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value R: Letetresgene Autoleucel
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: One hundred Eighteenth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value S: Iobenguane I-131 Antineoplastic
    Second choice is value W: Caplacizumab
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: One hundred Nineteenth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value W: Fosfomycin Anti-infective
  Seventh character (Qualifier) is value B: New Technology Group 11

FY2026: One hundred Twentieth panel of table X W 0
  Fourth character (Body Part) is value 5: Peripheral Artery
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 4: Stem Cells, Somatic
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: One hundred Twenty-first panel of table X W 0
  Fourth character (Body Part) is value 5: Peripheral Artery
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value T: Melphalan Hydrochloride Antineoplastic
  Seventh character (Qualifier) is value 9: New Technology Group 9

FY2026: One hundred Twenty-second panel of table X W 0
  Fourth character (Body Part) is value 6: Cerebral Ventricle
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 2: CPI-601 Enzyme Replacement Therapy
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: One hundred Twenty-third panel of table X W 0
  Fourth character (Body Part) is value D: Mouth and Pharynx
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value 3: Maribavir Anti-infective
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: One hundred Twenty-fourth panel of table X W 0
  Fourth character (Body Part) is value D: Mouth and Pharynx
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value 8: Uridine Triacetate
  Seventh character (Qualifier) is value 2: New Technology Group 2

No change: One hundred Twenty-fifth panel of table X W 0
  Fourth character (Body Part) is value D: Mouth and Pharynx
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value F: Other New Technology Therapeutic Substance
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: One hundred Twenty-sixth panel of table X W 0
  Fourth character (Body Part) is value D: Mouth and Pharynx
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value J: Quizartinib Antineoplastic
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: One hundred Twenty-seventh panel of table X W 0
  Fourth character (Body Part) is value D: Mouth and Pharynx
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value K: Sabizabulin
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: One hundred Twenty-eighth panel of table X W 0
  Fourth character (Body Part) is value D: Mouth and Pharynx
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value M: Baricitinib
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: One hundred Twenty-ninth panel of table X W 0
  Fourth character (Body Part) is value D: Mouth and Pharynx
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value N: SER-109
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: One hundred Thirtieth panel of table X W 0
  Fourth character (Body Part) is value D: Mouth and Pharynx
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value R: Fostamatinib
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: One hundred Thirty-first panel of table X W 0
  Fourth character (Body Part) is value D: Mouth and Pharynx
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value V: Xanomeline and Trospium Chloride
  Seventh character (Qualifier) is value B: New Technology Group 11

FY2026: One hundred Thirty-second panel of table X W 0
  Fourth character (Body Part) is value E: Ear(s)
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 3: DB-OTO via Intracochlear Infusion
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: One hundred Thirty-third panel of table X W 0
  Fourth character (Body Part) is value G: Upper GI
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value 3: Maribavir Anti-infective
    Second choice is value K: Sabizabulin
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: One hundred Thirty-fourth panel of table X W 0
  Fourth character (Body Part) is value G: Upper GI
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Device / Substance / Technology) is value M: Baricitinib
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: One hundred Thirty-fifth panel of table X W 0
  Fourth character (Body Part) is value G: Upper GI
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Device / Substance / Technology) is value R: Fostamatinib
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: One hundred Thirty-sixth panel of table X W 0
  Fourth character (Body Part) is value G: Upper GI
  Fifth character (Approach) is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Device / Substance / Technology) is value 8: Mineral-based Topical Hemostatic Agent
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: One hundred Thirty-seventh panel of table X W 0
  Fourth character (Body Part) is value H: Lower GI
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value 3: Maribavir Anti-infective
    Second choice is value K: Sabizabulin
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: One hundred Thirty-eighth panel of table X W 0
  Fourth character (Body Part) is value H: Lower GI
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Device / Substance / Technology) is value M: Baricitinib
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: One hundred Thirty-ninth panel of table X W 0
  Fourth character (Body Part) is value H: Lower GI
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Device / Substance / Technology) is value R: Fostamatinib
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: One hundred Fortieth panel of table X W 0
  Fourth character (Body Part) is value H: Lower GI
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Device / Substance / Technology) is value X: Broad Consortium Microbiota-based Live Biotherapeutic Suspension
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: One hundred Forty-first panel of table X W 0
  Fourth character (Body Part) is value H: Lower GI
  Fifth character (Approach) is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Device / Substance / Technology) is value 8: Mineral-based Topical Hemostatic Agent
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: One hundred Forty-second panel of table X W 0
  Fourth character (Body Part) has 4 choices.
    First choice is value J: Coronary Artery, One Artery
    Second choice is value K: Coronary Artery, Two Arteries
    Third choice is value L: Coronary Artery, Three Arteries
    Fourth choice is value M: Coronary Artery, Four or More Arteries
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 4 choices.
    First choice is value H: Paclitaxel-Coated Balloon Technology, One Balloon
    Second choice is value J: Paclitaxel-Coated Balloon Technology, Two Balloons
    Third choice is value K: Paclitaxel-Coated Balloon Technology, Three Balloons
    Fourth choice is value L: Paclitaxel-Coated Balloon Technology, Four or More Balloons
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: One hundred Forty-third panel of table X W 0
  Fourth character (Body Part) is value Q: Cranial Cavity and Brain
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 1: Eladocagene exuparvovec
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: One hundred Forty-fourth panel of table X W 0
  Fourth character (Body Part) is value U: Joints
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value G: Vancomycin Hydrochloride and Tobramycin Sulfate Anti-Infective, Temporary Irrigation Spacer System
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: One hundred Forty-fifth panel of table X W 0
  Fourth character (Body Part) is value U: Joints
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device / Substance / Technology) is value X: Peptide Enhanced Bone Void Filler
  Seventh character (Qualifier) is value B: New Technology Group 11

No change: One hundred Forty-sixth panel of table X W 0
  Fourth character (Body Part) is value V: Bones
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value P: Antibiotic-eluting Bone Void Filler
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: One hundred Forty-seventh panel of table X W 0
  Fourth character (Body Part) is value V: Bones
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value W: AGN1 Bone Void Filler
  Seventh character (Qualifier) is value A: New Technology Group 10
